Systems and methods including a human-shaped graphical element

ABSTRACT

Graphical user interfaces for use with extracorporeal blood treatment systems may include a human-shaped graphical element and one or more process feature graphical elements. The human-shaped graphical element may be moved automatically or manually by users with respect to the process feature graphical elements to provide indications with respect to the process features corresponding to the human-shaped graphical element and the process feature graphical elements.

This application claims the benefit of Swedish Patent Application No.1550939-1 filed on 2015 Jul. 2, which is incorporated by referenceherein in its entirety.

The disclosure herein relates to medical treatment apparatus. Moreparticularly, the disclosure relates to systems and methods for use inproviding graphical user interfaces related to medical treatmentapparatus such as extracorporeal blood treatment apparatus.

Medical treatment apparatus often includes a graphical user interfacedepicted on a display. A user may use the graphical user interface to,among other things, configure and setup a treatment, monitor and performa treatment, and perform various post-treatment processes. The graphicaluser interface for treatment apparatus may include a plurality ofdifferent graphical elements, graphical regions, and graphical areasconfigured for performing the functionality associated with thetreatment apparatus.

Medical treatment apparatus may be configured to perform extracorporealblood treatment. Extracorporeal blood treatment may refer to takingblood from a patient, treating the blood outside the patient, andreturning the treated blood to the patient. Extracorporeal bloodtreatment is typically used to extract undesirable matter or moleculesfrom the patient's blood, and/or to add beneficial matter or moleculesto the blood. Extracorporeal blood treatment may be used with patientsincapable of effectively eliminating such undesirable matter from theirblood, for example, in the case of a patient who is suffering fromtemporary or permanent kidney failure. These and other patients may, forinstance, undergo extracorporeal blood treatment to add to or toeliminate matter from their blood, to maintain an acid-base balance,and/or to eliminate excess body fluids.

SUMMARY

The present disclosure describes systems and methods that use, orutilize, graphical user interfaces that depict one or more processfeature graphical elements that may be moved about the graphical userinterface to, e.g., indicate changes to states of process featurescorresponding to (e.g., representative of, associated with, etc.) theone or more process feature graphical elements. For example, the processfeature graphical elements may be corresponding to fluid-circuit relatedprocess such as, e.g., dialysate processes, ultrafiltration processes,etc. and/or blood-circuit related processes such as, e.g., blood flow,blood priming, heparin delivery, citrate delivery, etc. The processfeature graphical elements may be movable by a user to initiate or stopone or more process features corresponding to the process featuregraphical elements. The movement of the process feature graphicalelements may engage or disengage physical apparatus on a treatmentsystem such as, e.g., connect the blood pump to the dialysate circuit.In one or more embodiments, the process feature graphical elements maybe described as being “dragged” and “connected” to other process featuregraphical elements (e.g., the process feature graphical elements may bereferred to as “drag-and-connect” process feature graphical elements).Further, the process feature graphical elements may be automaticallymoved by the system when the one or more process features correspondingto the process feature graphical elements are initiated or stopped.

Upon viewing the graphical user interface including the locations andpresentation of the process feature graphical elements, a user may beinformed of the present state of the process features corresponding to(e.g., representative of, associated with, etc.) the process featuregraphical elements. Further, the locations and presentation of theprocess feature graphical elements with respect each other and/or viewedas a whole may further provide additional information to the userregarding the present process features of the treatment system. In oneor more embodiments described herein, each process feature graphicalelement may represent a portion of a prescription for an extracorporealblood treatment, and the combination of the process feature graphicalelements on the graphical user interface may represent the completedprescription.

One exemplary extracorporeal blood treatment system may includeextracorporeal blood treatment apparatus for use during anextracorporeal blood treatment, a display apparatus, and a computingapparatus including one or more processors and operatively coupled tothe extracorporeal blood treatment apparatus and the display apparatus.The extracorporeal blood treatment apparatus may include a bloodpressure sensor to sense a patient's blood pressure. The displayapparatus may include a graphical user interface configured to depict ahuman-shaped graphical element and a heart-shaped graphical elementwithin the human-shaped graphical element. The computing apparatus maybe configured to display on the graphical user interface thehuman-shaped graphical element and the heart-shaped graphical element atleast partially within the human-shaped graphical element using the oneor more processors, allow a user to select the heart-shaped graphicalelement to initiate the blood pressure sensor to perform a bloodpressure measurement on the patient, determine the patient's bloodpressure using the blood pressure sensor in response to selection of theheart-shaped graphical element, and display the measured blood pressureof the patient on the graphical user interface.

One exemplary method for an extracorporeal blood treatment system mayinclude providing extracorporeal blood treatment apparatus for useduring an extracorporeal blood treatment. The extracorporeal bloodtreatment apparatus may include a blood pressure sensor to sense apatient's blood pressure. The exemplary method may include displaying ona graphical user interface a human-shaped graphical element and theheart-shaped graphical element within the human-shaped graphicalelement, allowing a user to select the heart-shaped graphical element toinitiate the blood pressure sensor to perform a blood pressuremeasurement on the patient, determining the patient's blood pressureusing the blood pressure sensor in response to selection of theheart-shaped graphical element, and displaying the measured bloodpressure of the patient on the graphical user interface.

In one or more embodiments, the measured blood pressure of the patientmay be displayed at least partially within the human-shaped graphicalelement on the graphical user interface.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method may further include, uponinitialization of the blood pressure sensor to perform a blood pressuremeasurement on the patient, graphically animating the heart-shapedgraphical element to indicate that the user has initiated a bloodpressure measurement and that the blood pressure measurement isoccurring using the blood pressure sensor. For example, the graphicalanimation of the heart-shaped graphical element may include theheart-shaped graphical element pulsating.

In one or more embodiments, the extracorporeal blood treatment apparatusmay further include a heart rate sensor to measure the patient's heartrate, and the computing apparatus may be further configured to executeor the method may further include allowing a user to select a heart ratearea of the human-shaped graphical element to initiate the heart ratesensor to perform a heart rate measurement, determining the patient'sheart rate using the heart rate sensor in response to selection of theheart rate area heart-shaped graphical element, and displaying themeasured heart rate of the patient on the graphical user interface.

In one or more embodiments, the extracorporeal blood treatment apparatusmay include one or more waste sensors to determine an amount of wastebeing removed from the patient, and the human-shaped graphical elementmay include graphical indicia indicative of the amount of waste removedfrom the patient.

In one or more embodiments, the human-shaped graphical element mayinclude a graphical facial expression configured to indicate happinesswhen an extracorporeal blood treatment is complete.

In one or more embodiments, the graphical user interface may beconfigured to depict a graphical representation of at least one of thevenous and arterial blood lines extending from the human-shapedgraphical element and another graphical element on the graphical userinterface to indicate that venous and arterial blood lines areconnecting the patient to a blood circuit of the extracorporeal bloodtreatment apparatus. Further, for example, the extracorporeal bloodtreatment apparatus may include one or more blood circuit pressuresensors to measure venous blood circuit pressure and arterial bloodcircuit pressure in the blood circuit. The graphical user interface maybe further configured to depict a blood circuit pressure graphicalrepresentation representative of at least one of venous blood pressureof the patient and arterial blood pressure of the patient measured bythe one or more blood circuit pressure sensors proximate the graphicaldepiction of at least one of the venous and arterial blood lines.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method may further include allowing a userto select a graphical area proximate or within the human-shapedgraphical element to display a patient information region on thegraphical user interface comprising patient-related information. Thepatient-related information may include at least one of a prescription,medication condition history, treatment history, a treatment summary,patient notes, and vital signs.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method may further include displaying onthe graphical user interface a blood process feature graphical elementusing the one or more processors. The human-shaped graphical element andthe blood process feature graphical element may be separated by space,and the human-shaped graphical element may be movable proximate theblood process feature graphical element to indicate that venous andarterial blood lines are connecting the patient to a blood circuit ofthe extracorporeal blood treatment apparatus. Further, for example thehuman-shaped graphical element may further include a connection areacorresponding to the blood process feature graphical element and theblood process feature graphical element may include a connection areacorresponding to the human-shaped graphical element. The connection areaof the human-shaped graphical element may be at least proximate to theconnection area of the blood process feature graphical element when thehuman-shaped graphical element is proximate the blood process featuregraphical element to indicate that venous and arterial blood lines areconnecting the patient to the blood circuit of the extracorporeal bloodtreatment apparatus. Still further, for example, the connection area ofthe human-shaped graphical element may be configured to be in at leastcontact with the connection area of the blood process feature graphicalelement when the human-shaped graphical element is proximate the bloodprocess feature graphical element.

An exemplary extracorporeal blood treatment system may includeextracorporeal blood treatment apparatus to perform an extracorporealblood treatment, a display apparatus, and a computing apparatusoperatively coupled to the extracorporeal blood treatment apparatus andthe display apparatus. The extracorporeal blood treatment apparatus mayinclude blood circuit to circulate blood from a patient during theextracorporeal blood treatment. The blood circuit may be connectable tothe patient using venous and arterial blood lines. The display apparatusmay include a graphical user interface configured to depict ahuman-shaped graphical element and one or more process feature graphicalelements. The human-shaped graphical element may be corresponding to(e.g., representative of, associated with, etc.) connection of a patient(e.g., a human) to the blood circuit using the venous and arterial bloodlines. Each process feature graphical element of the one or more processfeature graphical elements may be corresponding to (e.g., representativeof, associated with, etc.) a different process feature of theextracorporeal blood treatment system. The computing apparatus mayinclude one or more processors and may be configured to display on thegraphical user interface the human-shaped graphical element and the oneor more process feature graphical elements. The human-shaped graphicalelement and the one or more process feature graphical elements may beseparated by space, and the human-shaped graphical element may bemovable proximate (e.g., drag-and-connected to) the one or more processfeature graphical elements to indicate that the venous and arterialblood lines are connecting the patient to the blood circuit.

An exemplary method for an extracorporeal blood treatment system mayinclude providing extracorporeal blood treatment apparatus to perform anextracorporeal blood treatment. The extracorporeal blood treatmentapparatus may include blood circuit to circulate blood from a patientduring the extracorporeal blood treatment. The blood circuit may beconnectable to the patient using venous and arterial blood lines. Theexemplary method may include displaying on a graphical user interface ahuman-shaped graphical element and one or more process feature graphicalelements. The human-shaped graphical element may be corresponding to(e.g., representative of, associated with, etc.) connection of a patient(e.g., a human) to the blood circuit using the venous and arterial bloodlines. Each process feature graphical element of the one or more processfeature graphical elements may be corresponding to (e.g., representativeof, associated with, etc.) a different process feature of theextracorporeal blood treatment system. The human-shaped graphicalelement and the one or more process feature graphical elements may beseparated by space, and the human-shaped graphical element may bemovable proximate (e.g., drag-and-connected to) the one or more processfeature graphical elements to indicate that the venous and arterialblood lines are connecting the patient to the blood circuit.

Another exemplary extracorporeal blood treatment system may include anextracorporeal blood treatment apparatus to perform an extracorporealblood treatment, a display apparatus including a graphical userinterface, and a computing apparatus including one or more processors.The computing apparatus may be operatively coupled to the extracorporealblood treatment apparatus and the display apparatus. The extracorporealblood treatment apparatus may include blood circuit to circulate bloodfrom a patient during the extracorporeal blood treatment. The bloodcircuit may be connectable to the patient using venous and arterialblood lines. The graphical user interface may be configured to depict ahuman-shaped graphical element and one or more process feature graphicalelements. The human-shaped graphical element may correspond toconnection of a patient (e.g., a human) to the blood circuit using thevenous and arterial blood lines. Each process feature graphical elementof the one or more process feature graphical elements may correspond toa different process feature of the extracorporeal blood treatmentsystem. The computing apparatus may be configured to display on thegraphical user interface the human-shaped graphical element and the oneor more process feature graphical elements using the one or moreprocessors. The human-shaped graphical element and the one or moreprocess feature graphical elements may be separated by space. Thecomputing apparatus may be further configured to determine that thevenous and arterial blood lines are connecting the patient to the bloodcircuit and move the human-shaped graphical element using the one ormore processors proximate the one or more process feature graphicalelements in response to determining that the venous and arterial bloodlines are connecting the patient to the blood circuit.

Another exemplary method for an extracorporeal blood treatment systemmay include providing extracorporeal blood treatment apparatus toperform an extracorporeal blood treatment. The extracorporeal bloodtreatment apparatus may include blood circuit to circulate blood from apatient during the extracorporeal blood treatment. The blood circuit maybe connectable to the patient using venous and arterial blood lines. Theexemplary method may further include displaying on a graphical userinterface a human-shaped graphical element and one or more processfeature graphical elements. The human-shaped graphical element maycorrespond to connection of a patient (e.g., a human) to the bloodcircuit using the venous and arterial blood lines. Each process featuregraphical element of the one or more process feature graphical elementsmay correspond to a different process feature of the extracorporealblood treatment system, and the human-shaped graphical element and theone or more process feature graphical elements may be separated byspace. The exemplary method may further include determining that thevenous and arterial blood lines are connecting the patient to the bloodcircuit and moving the human-shaped graphical element proximate the oneor more process feature graphical elements in response to determiningthat the venous and arterial blood lines are connecting the patient tothe blood circuit.

In at least one embodiment, the extracorporeal blood treatment apparatusmay include a blood sensor to determine whether blood is in the bloodcircuit, and determining that the venous and arterial blood lines areconnecting the patient to the blood circuit may include sensing blood inthe blood circuit using the blood sensor.

Another exemplary extracorporeal blood treatment system may includeextracorporeal blood treatment apparatus to perform an extracorporealblood treatment, a display apparatus including a graphical userinterface, and a computing apparatus including one or more processors.The computing apparatus may be operatively coupled to the extracorporealblood treatment apparatus and the display apparatus. The extracorporealblood treatment apparatus may include blood circuit to circulate bloodfrom a patient during the extracorporeal blood treatment. The bloodcircuit may be connectable to the patient using venous and arterialblood lines. The graphical user interface may be configured to depict ahuman-shaped graphical element and one or more process feature graphicalelements. The human-shaped graphical element may correspond toconnection of a patient (e.g., a human) to the blood circuit using thevenous and arterial blood lines. Each process feature graphical elementof the one or more process feature graphical elements may correspond toa different process feature of the extracorporeal blood treatmentsystem. The computing apparatus may be configured to display on thegraphical user interface the human-shaped graphical element and the oneor more process feature graphical elements using the one or moreprocessors. The human-shaped graphical element proximate to the one ormore process feature graphical elements to show that the venous andarterial blood lines are connecting the patient to the blood circuit.The computing apparatus may be further configured allow a user to movethe human-shaped graphical element away from the one or more processfeature graphical elements to indicate to the one or more processorsthat the venous and arterial blood lines have been disconnected from thepatient.

The exemplary method for an extracorporeal blood treatment system mayinclude providing extracorporeal blood treatment apparatus to perform anextracorporeal blood treatment. The extracorporeal blood treatmentapparatus may include blood circuit to circulate blood from a patientduring the extracorporeal blood treatment. The blood circuit may beconnectable to the patient using venous and arterial blood lines. Theexemplary method may include displaying on a graphical user interface ahuman-shaped graphical element and one or more process feature graphicalelements. The human-shaped graphical element may correspond toconnection of a patient (e.g., a human) to the blood circuit using thevenous and arterial blood lines. Each process feature graphical elementof the one or more process feature graphical elements may correspond toa different process feature of the extracorporeal blood treatmentsystem. The human-shaped graphical element may be proximate to the oneor more process feature graphical elements to show that the venous andarterial blood lines are connecting the patient to the blood circuit.The exemplary method may further include allowing a user to move thehuman-shaped graphical element away from the one or more process featuregraphical elements to indicate to the one or more processors that thevenous and arterial blood lines are connecting the patient to the bloodcircuit.

In at least one embodiment, a confirmation region including, ordepicting, a query asking the user whether the patient is physicallydisconnected from the blood circuit may be displayed on the graphicaluser interface. The computing apparatus may be further configured toexecute or the method may further include allowing a user to answeraffirmatively or negatively to the query of the confirmation region andmoving the human-shaped graphical element proximate the one or moreprocess feature graphical elements in response to the user answering thequery negatively.

In one or more embodiments, the extracorporeal blood treatment apparatusmay include one or more waste sensors to determine an amount of wastebeing removed from the patient and the human-shaped graphical elementmay include graphical indicia indicative of an amount of waste beingremoved from the patient.

In one or more embodiments, the extracorporeal blood treatment apparatusmay include one or more blood-related parameter sensors to determine atleast one blood-related parameter associated with the patient and thehuman-shaped graphical element may include the at least oneblood-related parameter associated with the patient determined by theone or more blood-related parameter sensors.

In one or more embodiments, the human-shaped graphical element mayinclude a graphical facial expression configured to indicate happinesswhen an extracorporeal blood treatment is complete.

In one or more embodiments, the graphical user interface may beconfigured to depict a graphical representation of at least one of thevenous and arterial blood lines extending between the human-shapedgraphical element and the one or more process feature graphical elementsto indicate that the venous and arterial blood lines are connecting thepatient to the blood circuit. In at least one embodiment, theextracorporeal blood treatment apparatus may include one or more bloodcircuit pressure sensors to measure venous blood circuit pressure andarterial blood circuit pressure in the blood circuit and the graphicaluser interface may be further configured to depict a blood pressuregraphical representation representative of at least one of venous bloodpressure of the patient and arterial blood pressure of the patientmeasured by the one or more blood circuit pressure sensors proximate thegraphical representation of at least one of the venous and arterialblood lines.

In one or more embodiments, the graphical user interface may beconfigured to depict one or more affordance indications to indicate to auser where on the graphical user interface the one or more processfeature graphical elements and the human-shaped graphical element are tobe moved away from or proximate to. Further, the computing apparatus maybe further configured to execute or the method further may includedisplaying one or more affordance indications proximate locations whereon the graphical user interface the one or more process featuregraphical elements and the human-shaped graphical element are to bemoved away from or proximate to when the one or more process featuregraphical elements and the human-shaped graphical element are moved.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method may further include, uponinitialization of at least one process feature corresponding to the oneor more process feature graphical elements and the human-shapedgraphical element, displaying a graphical animation between at least twoof the one or more process feature graphical elements and thehuman-shaped graphical element indicative of the change of state of theprocess features corresponding to the one or more process featuregraphical elements and the human-shaped graphical element. In at leastone embodiment, the graphical animation includes a flow of particlesbetween a first process feature graphical element of the one or moreprocess feature graphical elements and a second process featuregraphical element of the one or more process feature graphical elements.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method may further include, uponinitialization of the process features corresponding to the one or moreprocess feature graphical elements and the human-shaped graphicalelement, displaying a graphical animation within the one or more processfeature graphical elements and the human-shaped graphical elementindicative of progression of the process features corresponding to theone or more process feature graphical elements and the human-shapedgraphical element.

In one or more embodiments, the human-shaped graphical element mayfurther include a connection area corresponding to a process featuregraphical element of the one or more process feature graphical elements.The connection area of the human-shaped graphical element may be atleast proximate to the corresponding process feature graphical elementwhen the human-shaped graphical element is moved proximate thecorresponding process feature graphical element graphical region toindicate a change in the state of the process feature corresponding tothe human-shaped graphical element. In at least one embodiment, theconnection area of the human-shaped graphical element may be configuredto be in at least contact with the corresponding process featuregraphical element when the human-shaped graphical element is movedproximate the corresponding process feature graphical element.

In one or more embodiments, after the human-shaped graphical element maybe moved proximate the one or more process feature graphical elements,the human-shaped graphical element overlaps the one or more processfeature graphical elements.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method may further include allowing a userto select the human-shaped graphical element to display a patientinformation region on the graphical user interface includingpatient-related information. The patient-related information may includeat least one of a prescription, a medical condition history, a treatmenthistory, a treatment summary, patient notes, and vital signs.

In one or more embodiments, the extracorporeal blood treatment apparatusmay include at least one of a blood pressure sensor to measure thepatient's blood pressure and a heart rate sensor to measure thepatient's heart rate, and the computing apparatus may be furtherconfigured to execute or the method further may include allowing a userto select an area of the human-shaped graphical element to initiate atleast one of a blood pressure measurement and a heart rate measurement.In at least one embodiment, the area of the human-shaped graphicalelement is heart-shaped.

In one or more embodiments, the computing apparatus may be furtherconfigured to execute or the method further may include displaying, inthe one or more process feature graphical elements and the human-shapedgraphical element, at least one parameter of the process featurescorresponding to the one or more process feature graphical elements andthe human-shaped graphical element and allowing a user to select the oneor more process feature graphical elements and the human-shapedgraphical element to display an adjustment region configured to allowadjustment of the at least one parameter.

In one or more embodiments, the one or more process feature graphicalelements may be representative of one or more blood-related processfeatures of the extracorporeal blood treatment, and the one or moreprocess feature graphical elements may be representative of one or morefluid circuit-related process features of the extracorporeal bloodtreatment.

In one or more embodiments, the one or more process feature graphicalelements may be corresponding to at least one of blood flow,ultrafiltration, heparin delivery, citrate delivery, dialysate delivery,priming, disinfection, ultrafiltration profile, isolatedultrafiltration, rinseback, sodium profile, bicarbonate profile,pre-dilution, post-dilution, and potassium profile.

In one or more embodiments, the one or more process feature graphicalelements may include at least two process feature graphical elements.

In one or more embodiments, the display apparatus may include atouchscreen.

The above summary of the present disclosure is not intended to describeeach embodiment or every implementation thereof. Advantages, togetherwith a more complete understanding of the present disclosure, willbecome apparent and appreciated by referring to the following detaileddescription and claims taken in conjunction with the accompanyingdrawings.

BRIEF DESCRIPTION OF THE DRAWING

FIG. 1 is a block diagram of an exemplary medical treatment systemincluding input apparatus, display apparatus, and treatment apparatusthat may utilize the graphical user interfaces and methods describedherein.

FIG. 2 is an illustration of an exemplary extracorporeal blood treatmentsystem that may include graphical user interfaces as described herein.

FIGS. 3A-3F depict an exemplary graphical user interface for use insetup and priming of a treatment using an extracorporeal blood treatmentsystem such as, for example, shown generally in FIGS. 1-2.

FIGS. 4A-4L depict an exemplary graphical user interface for use inperforming a treatment using an extracorporeal blood treatment systemsuch as, for example, shown generally in FIGS. 1-2.

FIGS. 5A-5B depict an exemplary graphical user interface for use inperforming a post-treatment process using an extracorporeal bloodtreatment system such as, for example, shown generally in FIGS. 1-2.

FIG. 6 depicts exemplary process feature graphical elements anduser-recognizable forms, or shapes, for use an exemplary graphical userinterfaces such as, for example, shown in FIGS. 3-5.

FIGS. 7A-7C depict an exemplary graphical user interface for use inperforming a treatment using an extracorporeal blood treatment systemsuch as, for example, shown generally in FIGS. 1-2.

FIGS. 8A-8F depict an exemplary graphical user interface for use inpreparing and performing a treatment using an extracorporeal bloodtreatment system such as, for example, shown generally in FIGS. 1-2.

FIG. 9 depicts an exemplary adjustment region for use in the graphicaluser interfaces of FIGS. 3-8.

DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

In the following detailed description of illustrative embodiments,reference is made to the accompanying figures of the drawing which forma part hereof, and in which are shown, by way of illustration, specificembodiments which may be practiced. It is to be understood that otherembodiments may be utilized and structural changes may be made withoutdeparting from (e.g., still falling within) the scope of the disclosurepresented hereby.

Exemplary graphical user interface systems and methods for use withmedical treatment apparatus such as, e.g., extracorporeal bloodtreatment apparatus, shall be described with reference to FIGS. 1-9. Itwill be apparent to one skilled in the art that elements or processesfrom one embodiment may be used in combination with elements orprocesses of the other embodiments, and that the possible embodiments ofsuch graphical user interface systems and methods using combinations offeatures set forth herein is not limited to the specific embodimentsshown in the Figures and/or described herein. Further, it will berecognized that the embodiments described herein may include manyelements that are not necessarily shown to scale. Still further, it willbe recognized that timing of the processes and the size and shape ofvarious elements herein may be modified but still fall within the scopeof the present disclosure, although certain timings, one or more shapesand/or sizes, or types of elements, may be advantageous over others.

The exemplary systems and/or methods may provide, or have, graphicaluser interfaces (e.g., user-interactable graphical user interfaces,graphical user interfaces depicted on single-touch or multi-touchtouchscreens, etc.) that include, or depict, a plurality of graphicalelements, graphical regions, and graphical areas configured to indicatethe status of one or more processes (e.g., processes of anextracorporeal blood treatment system such as processes that are part ofpreparing/priming for extracorporeal blood treatments, performingextracorporeal blood treatments, performing post-treatment processes,etc.). The plurality of graphical elements, graphical regions, andgraphical areas may each be configured to depict information (e.g.,information to be conveyed to a user viewing and/or using the graphicaluser interface) and/or to allow a user to modify states of the processesrelated to, or associated with, the graphical elements, graphicalregions, and graphical areas. Further, the plurality of graphicalelements, graphical regions, and graphical areas together (e.g., all ofthe graphical elements, graphical regions, and graphical areas, thepositioning of the graphical elements, graphical regions, and graphicalareas with respect to each other, the completeness and/or uniformity ofa user-recognizable form, or shape, defined by the graphical elements,graphical regions, and graphical areas positioned together, thegraphical elements, graphical regions, and graphical areas when viewedas whole, etc.) may further be configured to depict information (e.g.,information to be conveyed to a user viewing and/or using the graphicaluser interface) with respect to the processes related to, or associatedwith, each graphical element, graphical region, and/or graphical area aswell as one or more overall processes, of which the individual processesassociated with the graphical elements, graphical regions, and graphicalareas may be a part, or portion of.

An exemplary extracorporeal blood treatment system 10 depicted in FIG. 1may be used to execute, or perform, the exemplary methods and/orprocesses described herein. In at least one embodiment, the system 10may be a machine for the extracorporeal treatment of blood. The system10 could, for example, alternatively be a blood processing device or ablood component preparation device or other medical apparatus for fluiddelivery/collection.

As shown, the exemplary extracorporeal blood treatment system 10includes computing apparatus 12. The computing apparatus 12 may beconfigured to receive input from input apparatus 20 and transmit outputto display apparatus 22. Further, the computing apparatus 12 may includedata storage 14. Data storage 14 may allow for access to processingprograms or routines 16 and one or more other types of data 18 (e.g.,graphical regions, graphical elements, graphical areas, graphicalanimations, parameters, metrics, variables, images, text strings,macros, etc.) that may be employed to perform, or carry out, exemplarymethods and/or processes (e.g., displaying graphical user interfaces,allowing user interaction with graphical user interfaces, interpretingtouch gestures on a touchscreen (e.g., swipes, drags, press-and-hold,touches, presses, etc.), displaying graphical elements, displayingtextual elements, displaying status information, issuing alarms, runninga treatment, determining problems with a treatment, exchanging/changingreservoirs, notifying operators/users of problems, etc.) for use inperforming extracorporeal blood treatments. The computing apparatus 12may be operatively coupled to the input apparatus 20 and the displayapparatus 22 to, e.g., transmit data to and from each of the inputapparatus 20 and the display apparatus 22. For example, the computingapparatus 12 may be electrically coupled to each of the input apparatus20 and the display apparatus 22 using, e.g., analog electricalconnections, digital electrical connections, wireless connections,bus-based connections, etc. As described further herein, an operator mayprovide input to the input apparatus 20 to manipulate, or modify, one ormore graphical elements, graphical regions, and graphical areasdisplayed on the display apparatus 22 to, e.g., initiate one or moreactions and/or processes related to the extracorporeal blood treatmentsystem, indicate one or more actions and/or statuses related to one ormore processes of the extracorporeal blood treatment system, etc.

Further, various devices and apparatus may be operatively coupled to thecomputing apparatus 12 to be used with the computing apparatus 12 toperform one or more extracorporeal procedures/treatments as well as thefunctionality, methods, and/or logic described herein. As shown, thesystem 10 may include input apparatus 20, display apparatus 22, andtreatment apparatus 24 operatively coupled to the computing apparatus 12(e.g., such that the computing apparatus 12 may be configured to useinformation, or data, from the apparatus 20, 22, 24 and provideinformation, or data, to the apparatus 20, 22, 24). The input apparatus20 may include any apparatus capable of providing input to the computingapparatus 12 to perform the functionality, methods, and/or logicdescribed herein.

For example, the input apparatus 20 may include a touchscreen (e.g.,capacitive touchscreen, a resistive touchscreen, a multi-touchtouchscreen, etc.), a mouse, a keyboard, a trackball, etc. A touchscreenmay overlay the display apparatus 22 such that, e.g., an operator mayuse the touchscreen to interact (e.g., by touch) with a graphical userinterface displayed on the display apparatus 22. For example, the inputapparatus 20 may allow an operator to interact with a graphical userinterface including an operation region containing, or depicting,graphical elements, graphical regions, and graphical areas associatedwith and representative of one or more process features to, e.g., changestates of such process features, start or initiate such processfeatures, stop or cease such process features, etc. when used inconjunction with the display apparatus 22 (e.g., displaying thegraphical user interface). Further, for example, the input apparatus 20may allow an operator to interact with a graphical user interfaceincluding a setup region containing, or depicting, information relatedto the setting up of an extracorporeal blood treatment to, e.g., modifyone or more treatment parameters, change the type of treatment, etc.when used in conjunction with the display apparatus 22 (e.g., displayingthe graphical user interface).

The display apparatus 22 may include any apparatus capable of displayinginformation to an operator, such as a graphical user interface, etc., toperform the functionality, methods, and/or logic described herein. Forexample, the display apparatus 22 may include a liquid crystal display,an organic light-emitting diode screen, a touchscreen, a cathode raytube display, etc. As described further herein, the display apparatus 22may be configured to display a graphical user interface that includesone or more graphical regions, graphical elements, and graphical areas.

For example, the graphical user interface displayed by the displayapparatus 22 may include, or display, an operation region that mayinclude multiple process feature graphical elements related to theextracorporeal blood treatment system. Each process feature graphicalelement may correspond to at least one feature of a process (e.g., flowrate, connection status, etc.). For example, a process feature graphicalelement may be associated with blood flow, and another process featuregraphical element may be associated with dialysate flow. Each of theseprocess feature graphical elements may be used by an operator to viewstatus information corresponding to at least one process featureassociated therewith. For example, the blood flow process featuregraphical element may include information related to the blood flow rateand/or the blood circuit connection status (e.g., whether the bloodcircuit is operatively coupled to the dialysate/filtration circuit toperform an extracorporeal blood treatment, etc.), and the dialysate flowprocess feature graphical element may include information related todialysate flow rate and/or the dialysate circuit connection status(e.g., whether the dialysate circuit is coupled to the blood/filtrationcircuit to perform an extracorporeal blood treatment, etc.).

Further, each process feature graphical element may correspond to one ormore physical parts or portions (e.g., blood circuit, dialysate circuit,ultrafiltration circuit, blood connection to patient, etc.) of anexemplary extracorporeal blood treatment system. For example, moving(e.g., dragging-and-connecting) a process feature graphical element toanother process feature graphical element may correspond to a physicalpart of the treatment system being physically coupled to another part ofthe treatment system. Further, for example, moving a process featuregraphical element related to blood to a process feature graphicalelement related to dialysate may physically, operatively couple theblood circuit to the dialysate circuit. In other words, the processfeature graphical elements may be related to, associated with, and/orrepresentative of one or more physical parts or portions of an exemplaryextracorporeal blood treatment system, and manipulating (e.g., moving,selecting, etc.) the process feature graphical elements may affect, orbe reflective of, the physical parts or portions of the system.Additionally, it may be described that the process feature graphicalelements are “linked” to the physical parts or portions an exemplaryextracorporeal blood treatment system. Likewise, physical manipulation(e.g., physically moving, physically disconnecting/connecting,physically touching, etc.) of one or more parts or portions of anexemplary extracorporeal blood treatment system may affect the one ormore process feature graphical elements corresponding to the physicallymanipulated parts or portions. For example, disconnecting a patient fromthe blood circuit may automatically initiate the movement of a bloodprocess feature graphical element about the graphical user interface.

As used herein, a “region” of a graphical user interface may be definedas a portion of the graphical user interface within which informationmay be displayed or functionality may be performed. Regions may existwithin other regions, which may be displayed separately orsimultaneously. For example, smaller regions may be located withinlarger regions, regions may be located side-by-side, etc. Additionally,as used herein, an “area” of a graphical user interface may be definedas a portion of the graphical user interface located within a regionthat is smaller than the region within which the area is located. Stillfurther, as used herein, an “element” of a graphical user interface maybe defined as a component of the graphical user interface that may belocated within, or adjacent to, a region, an area, or another element.In one or more embodiments, an “element” of a graphical user interfacemay include a perimeter, or border, defining the outer edge, orboundary, of the element. In one or more embodiments, an “element” of agraphical user interface is a defined, finite portion, item, and/orsection of a graphical user interface.

The processing programs or routines 16 may include programs or routinesfor performing computational mathematics, touchscreen gestureinterpretation algorithms, process performance algorithms, processautomation algorithms, matrix mathematics, standardization algorithms,comparison algorithms, or any other processing required to implement oneor more exemplary methods and/or processes described herein. Data 18 mayinclude, for example, variables, graphics (e.g., graphical elements,graphical areas, graphical regions, icons, buttons, windows, dialogs,pull-down menus, 3D graphics, images, animations, etc.), graphical userinterfaces, alarm data, fluid data, flow rates, fluid volumes,notifications, pressures, pressure limits, blood flow, blood flowlimits, fluid removal rates, fluid removal limits, target bloodtemperatures, blood temperature limits, heuristics indicative ofmalfunction, results from one or more processing programs or routinesemployed according to the disclosure herein, or any other data that maybe necessary for carrying out the one and/or more processes or methodsdescribed herein.

In one or more embodiments, the system 10 may be implemented using oneor more computer programs executed on programmable computers, such ascomputers that include, for example, processing capabilities, datastorage (e.g., volatile or non-volatile memory and/or storage elements),input devices, and output devices. Program code and/or logic describedherein may be applied to input data to perform functionality describedherein and generate desired output information. The output informationmay be applied as input to one or more other devices and/or methods asdescribed herein or as would be applied in a known fashion.

The program used to implement the methods and/or processes describedherein may be provided using any programmable language, or code, e.g., ahigh level procedural and/or object orientated programming language orcode that is suitable for communicating with a computer system. Any suchprograms may, for example, be stored on any suitable device, e.g., astorage media, that is readable by a general or special purpose programrunning on a computer system (e.g., including processing apparatus) forconfiguring and operating the computer system when the suitable deviceis read for performing the procedures described herein. In other words,at least in one embodiment, the system 10 may be implemented using acomputer readable storage medium, configured with a computer program,where the storage medium so configured causes the computer to operate ina specific and predefined manner to perform functions described herein.Further, in at least one embodiment, the system 10 may be described asbeing implemented by logic (e.g., object code) encoded in one or morenon-transitory media that includes code for execution and, when executedby a processor, is operable to perform operations such as the methods,processes, and/or functionality described herein.

The computing apparatus 12 may be, for example, any fixed or mobilecomputer system (e.g., a controller, a microcontroller, a personalcomputer, mini computer, etc.). The exact configuration of the computingapparatus 12 is not limiting, and essentially any device capable ofproviding suitable computing capabilities and control capabilities(e.g., graphics processing, control of extracorporeal blood treatmentapparatus, etc.) may be used.

As described herein, a digital file may be any medium (e.g., volatile ornon-volatile memory, a CD-ROM, a punch card, magnetic recordable tape,etc.) containing digital bits (e.g., encoded in binary, trinary, etc.)that may be readable and/or writeable by computing apparatus 12described herein. Also, as described herein, a file in user-readableformat may be any representation of data (e.g., ASCII text, binarynumbers, hexadecimal numbers, decimal numbers, graphically, etc.)presentable on any medium (e.g., paper, a display, etc.) readable and/orunderstandable by an operator.

In view of the above, it will be readily apparent that the functionalityas described in one or more embodiments according to the presentdisclosure may be implemented in any manner as would be known to oneskilled in the art. As such, the computer language, the computer system,or any other software/hardware which is to be used to implement theprocesses described herein shall not be limiting on the scope of thesystems, processes or programs (e.g., the functionality provided by suchsystems, processes or programs) described herein.

The methods and/or logic described in this disclosure, including thoseattributed to the systems, or various constituent components, may beimplemented, at least in part, in hardware, software, firmware, or anycombination thereof. For example, various aspects of the techniques maybe implemented within one or more processors, including one or moremicroprocessors, DSPs, ASICs, FPGAs, or any other equivalent integratedor discrete logic circuitry, as well as any combinations of suchcomponents, or other devices. The term “processor” or “processingcircuitry” may generally refer to any of the foregoing logic circuitry,alone or in combination with other logic circuitry, or any otherequivalent circuitry.

Such hardware, software, and/or firmware may be implemented within thesame device or within separate devices to support the various operationsand functions described in this disclosure. In addition, any of thedescribed components may be implemented together or separately asdiscrete but interoperable logic devices. Depiction of differentfeatures, e.g., using block diagrams, etc., is intended to highlightdifferent functional aspects and does not necessarily imply that suchfeatures must be realized by separate hardware or software components.Rather, functionality may be performed by separate hardware or softwarecomponents, or integrated within common or separate hardware or softwarecomponents.

When implemented in software, the functionality ascribed to the systems,devices and methods described in this disclosure may be embodied asinstructions and/or logic on a computer-readable medium such as RAM,ROM, NVRAM, EEPROM, FLASH memory, magnetic data storage media, opticaldata storage media, or the like. The instructions and/or logic may beexecuted by one or more processors to support one or more aspects of thefunctionality described in this disclosure.

The treatment apparatus 24 may include any apparatus used by anexemplary extracorporeal blood treatment system capable of performingextracorporeal blood treatments, such as, e.g., pumps, reservoirs,scales, treatment sets, filters, pressure sensors, etc. For example, thetreatment apparatus 24 may include one or more elements, or components,of the extracorporeal blood treatment system 100 described herein withreference to FIG. 2.

The exemplary systems, and exemplary methods performed, or used, by suchexemplary systems, described herein may include systems such as, e.g.,dialysis systems. The general term “dialysis” as used herein includeshemodialysis, hemofiltration, hemodiafiltration, hemoperfusion, liverdialysis, and therapeutic plasma exchange (TPE), among other similartreatment procedures. In dialysis generally, blood is taken out of thebody and exposed to a treatment device to separate substances therefromand/or to add substances thereto, and is then returned to the body.Although extracorporeal blood treatment systems capable of performinggeneral dialysis (as defined above, including TPE) shall be describedherein with reference to the exemplary extracorporeal blood treatmentsystem of FIG. 2, other systems such as those for infusion of drugs,performance of continuous renal replacement therapy (CRRT),extracorporeal membrane oxygenation (ECMO), hemoperfusion, liverdialysis, apheresis, TPE, etc. may benefit from the systems, methods,and apparatus described herein and the present disclosure is not limitedto any particular treatment system.

Referring to FIG. 2, one illustrative embodiment of an extracorporealblood treatment system, or apparatus, 100 is depicted. The system 100includes a housing 110 having a front face 112. The system 100 furtherincludes one or more pumps 120, one or more disposable elements 140(e.g., including or part of integrated modules), and one or more sensors142 for use in performing one or more extracorporeal blood treatments.The one or more pumps 120 may be used to move liquids through the systemas part of a treatment process. Although the pumps 120 are depicted inthe form of peristaltic pumps, the pumps used in the extracorporealblood treatment system described herein may be provided in a variety ofalternative forms, e.g., piston pumps, pumps for use with syringes,diaphragm pumps, etc. and/or may not be visible on the outside of thehousing 110. The one or more disposable elements 140 may be coupled tothe system 100 for using in performing the extracorporeal bloodtreatment. The one or more disposable elements 140 may include one ormore fluid circuits such as, e.g., dialysis or dialysate fluid circuits,blood circuits, etc. and/or one or more blood treatment units such as,e.g., filters, etc. In at least one embodiment, a disposable element 140is a cartridge or integrated unit including a plurality of various partsor portions configured to perform the extracorporeal blood treatment.Additionally, the one or more disposable elements 140 may includecontainers, or vessels, containing, or holding, one or more substancesfor use in the performance of the extracorporeal blood treatment. Forexample, a disposable element 140 may include a container, or vessel,holding bicarbonate, citrate, and/or dialysate/dialysis fluid, which maybe operatively coupled to the dialysis/dialysate fluid circuit. Further,the disposable elements 140 may be described as providing at least aportion of the extracorporeal blood treatment fluid circuit that may beoperatively coupled to one or more pumps 120 and one or more sensors 142of the system 100 for use in performing extracorporeal blood treatments.As shown, two disposable elements 140 appear to be coupled to the frontface 112 of the housing 110 of the system 100 to, e.g., integrate withthe one or more other fluid circuits, pumps 120, and sensors 142 of thesystem 100.

As described herein, the one or more disposable elements 140 may bedescribed as including one or more disposable fluid circuits and one ormore blood treatment units operatively coupled to the one or moredisposable fluid circuits. The one or more disposable elements 140 maybe further described as including a blood circuit for receiving,circulating, and returning blood from/to a patient. The blood circuitmay include one or more blood lines (e.g., as part of a disposableelement). Further, the one or more disposable elements 140 may befurther described as including a dialysis/dialysate circuit operativelycoupled, or couplable, to the blood circuit to remove waste from theblood of the patient. The dialysis/dialysate circuit may receive,circulate, and return dialysis/dialysate fluid (e.g., returningdialysis/dialysate fluid including waste). The dialysis/dialysatecircuit may include one or more dialysis/dialysate lines (e.g., as partof a disposable element 140). The blood treatment units may be, forexample, a plasma filter, a hemodialysis filter, a hemofiltrationfilter, etc. Generally, the blood treatment units may be referred to as“filters.”

As described herein, the system 100 may further include one or moresensors 142. As shown, two sensors 142 are identified on the system 100.One sensor 142 is located on, or coupled to, the front surface 112 ofthe housing 110 and another sensor 142 is located on the, or coupled to,the disposable elements 140. Additionally, the system 100 may includesensors 142 that are not visible on the outside of the housing 110, andinstead, may be internal to the system 100 (e.g., within the housing110). Generally, the system 100 may include any one or more sensors 142so as to be able to monitor any value (e.g., any aspect, setting, level,condition, event internal to the system 100, etc.) of any processfeature of the system 100 such as, e.g., process features during theperformance of one or more extracorporeal blood treatments. For example,the system 100 may include one or more pressure sensors 142 operable tomeasure, or monitor, various pressures of various circuits, chambers,pods, reservoirs, etc. of the system 100, e.g., during the performanceof an extracorporeal blood treatment, during the performance of apre-treatment process, during the performance of a disinfection,post-treatment process, etc. Further, for example, the system 100 mayinclude one or more flow rate sensors 142 operable to measure, ormonitor, various fluid flow rates of fluids within various circuits,chambers, pods, reservoirs, etc. of the system 100, e.g., during theperformance of an extracorporeal blood treatment, during the performanceof a pre-treatment process, during the performance of a disinfection,post-treatment process, etc. Specifically, the system 100 may includeone or more blood-related parameter sensors 142 such as, e.g., flow ratesensors to monitor various blood flow rates throughout the bloodcircuits of the system 100, blood pressure sensors to monitor thediastolic and systolic blood pressure of the patient, blood circuitpressure sensors to monitor the arterial and venous blood linespressures, heart rate sensors to measure the patient's heart rate, etc.Further, for example, the system 100 may include one or more wastesensors 142 configured to, or operable, to measure, or monitor, anamount of waste being removing from a patient (e.g., from a patient'sblood), e.g., during the performance of an extracorporeal bloodtreatment. Further, for example the system 100 may include one or morefluid circuit or lines sensors 142 such as, e.g., blood circuit sensorsto detect whether a blood circuit is coupled or uncoupled to the system,dialysate/dialysis fluid circuit sensors to detect whether adialysate/dialysis circuit is coupled or uncoupled to the system, etc.In other words, one or more blood circuit sensors may be configured todetect whether a blood circuit is operatively coupled to the remainderof the extracorporeal blood treatment apparatus for use in anextracorporeal blood treatment and/or one or more dialysate/dialysisfluid circuit sensors may be configured to detect whether adialysate/dialysis circuit is operatively coupled to the remainder ofthe extracorporeal blood treatment apparatus for use in anextracorporeal blood treatment. In one or more embodiments, the bloodcircuit and dialysate/dialysis fluid circuits may include some or all ofthe same sensors (e.g., when the blood circuit and dialysate/dialysisfluid circuit are part of the same disposable element or cartridge).Still further, for example, the system 100 may include other sensors 142such as fluid level sensors, temperature sensors, leak detectionsensors, etc. that may be used before an extracorporeal blood treatmentis performed, during the performance of an extracorporeal bloodtreatment, and/or after an extracorporeal blood treatment is performed.

Additionally, the extracorporeal blood treatment fluid circuit of thesystem 100 may be described as being completed by a combination of thedisposable elements 140 and the system 100 and may be generallydescribed as defining a blood circuit that removes blood from a patient,for example, via a catheter inserted in a vascular access of thepatient, and takes the blood though a blood removal line. Then, theblood may pass through a chamber (e.g., a blood chamber) and, via areturn line, may be transported back to the patient.

In one or more embodiments, the extracorporeal blood treatment system100 may be configured for acute blood treatments (e.g., continuous renalreplacement therapy) and may also include one or more devices,apparatus, and structures configured to perform the acute bloodtreatments. For example, the extracorporeal blood treatment system 100may include reservoir sensors, or scales, (e.g., weight sensors, loadcells, etc.), each of which is configured to hold and weigh a reservoir.The reservoir sensors may be positioned below the bottom end of thehousing 110, at least in part because the reservoirs are typicallyattached to and hang from the reservoir sensors. The extracorporealblood treatment systems described herein may include one or morereservoir sensors and associated reservoirs such as, e.g., as few as tworeservoirs sensors and associated reservoirs, four or more reservoirssensors and associated reservoirs, etc.

The extracorporeal blood treatment system 100 further includes a venousblood line/circuit 130 extending from a patient 101 (symbolicallyrepresented in FIG. 2) to the housing 110 to return blood to the patient101 after the blood is treated by the system 100, an arterial bloodline/circuit 132 extending from the patient 101 to the housing 110 towithdraw blood from the patient 101 for treatment, a venous bloodcircuit pressure sensor 134 configured to measure, or monitor, thepressure of the venous blood line/circuit 130 (e.g., the pressure of theblood, or fluid, within the venous blood line/circuit 130), and anarterial blood circuit pressure sensor 136 configured to measure, ormonitor, the pressure of the arterial blood line/circuit 132 (e.g., thepressure of the blood, or fluid, within the arterial blood line/circuit132). The venous and arterial blood circuits 130, 132 may connect thepatient to a blood circuit (e.g., a disposable element 140) such that,e.g., blood of the patient may be circulated through the blood circuitto perform blood treatments thereon. In other words, the blood circuitmay be connectable to a patient using the venous and arterial bloodlines 130, 132.

The extracorporeal blood treatment system 100 also includes, in one ormore embodiments, a display 160 used to show, or convey, information toan operator or user. The display 160 may also serve as an input deviceif, e.g., the display 160 is in the form of a touchscreen (e.g., a userinteractable graphical user interface, etc.). Also, although the display160 is depicted as being located in the housing 110, in one or morealternate embodiments, the display 160 may be separate from the housing110 of the extracorporeal blood treatment system 100. For example, thedisplay 160 may be movably (e.g., swivel, tilt, etc.) attached, orcoupled, to the housing 110 (e.g., a top end of the housing 110).

As shown in FIG. 1 and as related to FIG. 2, the treatment apparatus 24may be operatively coupled, or connected, to the computing apparatus 12.Among the treatment apparatus 24 operably coupled to the computingapparatus 12 are the pumps 120, blood circuits 130, 132, blood circuitpressure sensors 134, 136, and disposable elements 140 as shown in FIG.2.

Exemplary graphical user interfaces, or portions thereof, for use indisplaying information related to extracorporeal blood treatments,providing functionality to an operator for use in preparing andperforming extracorporeal blood treatments and/or configuring ormaintaining an extracorporeal blood treatment system are depicted inFIGS. 3-8. Such exemplary graphical user interfaces may be depicted bythe display apparatus 22 of the system 10 described herein withreference to FIG. 1 and/or the display 160 of the system 100 of FIG. 2.Additionally, the graphical user interfaces described herein may bedepicted on a touchscreen, and in such configuration, the inputapparatus would also be the touchscreen.

Exemplary extracorporeal blood treatment systems may use, or utilize, aplurality of different graphical user interfaces. For example, someexemplary graphical user interfaces may be used to setup, or prepare, anextracorporeal blood treatment. Further, for example, some exemplarygraphical user interfaces may be used during an extracorporeal bloodtreatment to monitor and/or adjust one or more parameters of theextracorporeal blood treatment. Still further, for example, someexemplary graphical user interfaces may be used post-treatment toclean/disinfect the system and to prepare the system for the nexttreatment. And still further, for example, some exemplary graphical userinterfaces may be used to review system data regarding the performanceand maintenance of the extracorporeal blood treatment system.

Each exemplary graphical user interface of the exemplary extracorporealblood treatment systems described herein may include one or moregraphical elements, regions, and areas used to display information to auser. An operator may use input apparatus 20 of the exemplaryextracorporeal blood treatment system 10 described herein with referenceto FIG. 1 to select or manipulate graphical elements, regions, and areasof the exemplary graphical user interfaces of FIGS. 3-8. As used herein,when an operator “selects” or “interacts with” a graphical element,area, and/or region of the graphical user interface, it is to beunderstood that “selecting” or “interacting with” the graphical element,area, and/or region to perform one or more tasks or steps may beconducted in many different ways using many different types of inputapparatus. For example, when the input apparatus includes a touchscreen, an operator may select or interact with a graphical element,area, and/or region by “touching” the graphical region with their fingeror using a pointing device such as a stylus. Further, for example, whenthe input apparatus includes a mouse or similar pointing device, anoperator may select or interact with a graphical element, area, and/orregion by locating an arrow or cursor over the desired graphical region“clicking” the graphical region. Still further, for example, when theinput apparatus includes a series of buttons and/or knobs, an operatormay select or interact with a graphical element, area, and/or region byusing the buttons and/or knobs to navigate to the graphical region andto select it (e.g., by depressing the button and/or knob). Additionally,it is to be understood that selection of or interaction with a graphicalelement, area, and/or region may be conducted using various gesturessuch as, for example, but not limited to, swipes, select-and-drag,press, tracing of various shapes, pinch-inwardly, pinch-outwardly,finger spread, multi-finger touches and/or swipes, etc.

An exemplary graphical user interface 200 is depicted in FIGS. 3A-3Fthat may be generally used to configure, or “set up,” an extracorporealblood treatment before the extracorporeal blood treatment is performed.As shown, the graphical user interface 200 may include a plurality ofgraphical regions that may be used in the preparation of anextracorporeal blood treatment as well as other functionality and/orprocesses of the extracorporeal blood treatment system. At least one ofthe graphical regions may be more specifically referred to as anoperation region 201, which is located within (e.g., located centrallywithin) the exemplary graphical user interface 200.

The operation region 201 may include various graphical regions, areas,and elements that may be used to indicate, initiate, revert, and stopone or more process features of processes of the extracorporeal bloodtreatment system. In the exemplary graphical user interface 200, theoperation region 201 includes a plurality of process feature graphicalelements such as, e.g., process feature graphical elements 212, 214,216.

Each of the process feature graphical elements may be described as beingcorresponding to (e.g., representative of, associated with, etc.) atleast one process feature of the extracorporeal blood treatment system.In the exemplary graphical user interface 200 depicted in FIGS. 3A-3F,the process feature graphical element 212 is corresponding to (e.g.,representative of, associated with, etc.) the blood circuit, the processfeature graphical element 214 is corresponding to (e.g., representativeof, associated with, etc.) the dialysate circuit, and the processfeature graphical element 214 is corresponding to (e.g., representativeof, associated with, etc.) ultrafiltration. Further, collectively, theprocess feature graphical elements 212, 214, 216 may be described asbeing corresponding to (e.g., representative of, associated with, etc.)an overall, or primary, process. In the exemplary graphical userinterface 200, the process feature graphical elements 212, 214, 216 arecollectively corresponding to hemodialysis setup and priming, which maybe indicated in title graphical region 203. In other words, the processfeature graphical elements 212, 214, 216 may be used together, or inconjunction, to perform an overall, primary, process such ashemodialysis setup and priming. Additionally, as described herein, theprocess feature graphical elements 212, 214, 216 may also correspond to(e.g., representative of, associated with, etc.) one or more physicalparts or portions of an extracorporeal blood treatment system relatedto, or linked to, the processes corresponding to the process featuregraphical elements 212, 214, 216.

The operation region 201 of the exemplary graphical user interface 200may further include a primary region 220. The primary region 220 may bedescribed as a region of the operation region 201 and graphical userinterface 200 that is spatially related to the plurality of processfeature graphical elements 212, 214, 216 such that the position, orlocation, of the process feature graphical elements 212, 214, 216 withrespect to the primary region 220 may be indicative of the states of theprocess features represented by and associated with the process featuregraphical elements 212, 214, 216. In other words, the primary region 220may be described as a central operating point or area from which theprocess feature graphical elements 212, 214, 216 may be located about,and the distance the process feature graphical elements 212, 214, 216are located away from the primary region 220 (e.g., the centraloperating point) may indicate to a user (e.g., at a glance or quicklook) the status of the process features represented by and associatedwith such process feature graphical elements 212, 214, 216. In otherwords, the primary region 220 may be described as a central operatingpoint or area from which the process feature graphical elements 212,214, 216 may be located about, and the distance the process featuregraphical elements 212, 214, 216 are located away from the primaryregion 220 (e.g., the central operating point) may indicate to a user(e.g., at a glance or quick look) the status of the process featuresrepresented by and associated with such process feature graphicalelements 212, 214, 216. In one or more embodiments, the primary region220 may be stationary (e.g., the primary region 220 may not move or beallowed to be moved about the graphical user interface 200). In one ormore embodiments, the primary region 220 may at least be temporallymoveable about the graphical user interface 200. Further, in one or moreembodiments, the primary region 220 may re-sizeable. For example, theprimary region 220 (and the graphical regions, areas, elements, etc.thereof) may be expanded (e.g., increased in size, maximized, etc.)and/or shrunk (e.g., decreased in size, minimized, etc.) on thegraphical user interface 200.

Additionally, in some embodiments, the primary region 220 may bedescribed as a central control region configurable to perform, orinitiate, one or more processes regardless of the state, or phase, ofother processes of an exemplary extracorporeal blood treatment system.For example, the primary region 220, as will be described herein, may beused as a “Start” and “Stop” button for one or more pumps of theexemplary system, which may be used to either start or stop the one morepumps regardless of the state, or phase, of the exemplary system (e.g.,within a treatment cycle, etc.). In other words, the primary region 220may be described as being an independent, or “master,” switch that isnot dependent on other process features that may be controllable byother graphical regions, areas, and/or elements of the graphical userinterface.

Also, in one or more embodiments, the primary region 220 may often bethe next, or final, step in a process flow, or work flow, after one ormore process features have been setup for a particular process. Forexample, after the system has been configured for priming, the next, orfinal, step to begin priming may be selection of the primary region 220to initiate, or start, the priming. Further, for example, after thesystem has been primed and a patient has been operatively coupled to thesystem for treatment, the next, or final, step may be selection of theprimary region 220 to initiate, or start, the blood pump.

Each process feature represented by and associated with the processfeature graphical elements 212, 214, 216 may be configured in at leastan active or inactive state. When a process feature is described to beconfigured in an inactive state, the process feature may, e.g., not beready to execute or perform, not be presently performing, have one ormore setup procedures before being ready to execute, etc. In otherwords, a process feature configured in an inactive state, which may beindicated by the process feature graphical element associated therewithalso being configured in an inactive state as will be further describedherein, may be not be ready for performing the one or more tasksassociated with the process feature. Likewise, when a process feature isdescribed to be configured in an active state, the process feature may,e.g., be ready to execute or perform, be presently performing, etc. Inother words, a process feature configured in an active state, which maybe indicated by the process feature graphical element associatedtherewith also being configured in an active state as will be furtherdescribed herein, may be ready for performing or may be presentlyperforming the one or more tasks associated with the process feature.

The process feature graphical elements 212, 214, 216 may be configuredto indicate on the graphical user interface 200 the states (e.g.,active, inactive, dormant, etc.) of the process features represented byand associated with the process feature graphical elements 212, 214,216. The process feature graphical elements 212, 214, 216 may indicatethe states of the process features in many different ways such as, e.g.,alphanumerically, graphically through animation, graphically throughcolors or highlighting, spatially, changes in graphical form, flashing,etc. Additionally, the states of various process features may beindicated auditorily. For example, the treatment system may output oneor more sounds corresponding to changes in the states of one or moreprocess features. Further, for example, the treatment system may outputone or more sounds corresponding to the present state of one or moreprocess features.

As shown in FIG. 3A, the plurality of process feature graphical elements212, 214, 216 may indicate the states of the process featuresrepresented by and associated therewith spatially. For example, theplurality of process feature graphical elements 212, 214, 216 and theprimary region 220 may be separated by space 207, and the space 207 mayindicate that the plurality of process feature graphical elements 212,214, 216 are configured in an inactive, or latent, state. Likewise, theprocess features corresponding to the process feature graphical elements212, 214, 216 that are in the inactive state may also be inactive (e.g.,the processes may not be ready to execute, the processes may not bepresently performing, etc.). Further, it may be described that theinactive process feature graphical elements may be visualized bydetachment from the primary region 220. Conversely, for example, as willbe described further herein, the plurality of process feature graphicalelements 212, 214, 216 and the primary region 220 may not be separatedby space 207, or at least less space 207 than when configured in theinactive state, to indicate that the plurality of process featuregraphical elements 212, 214, 216 are configured in an active, or ready,state. Likewise, the process features corresponding to the processfeature graphical elements that are configured in the active state mayalso be active (e.g., the processes may be ready to execute, theprocesses may be presently performing, etc.). Further, it may bedescribed that the active process feature graphical elements may bevisualized by attachment to the primary region 220.

Further, it may be described that the space 207 between a processfeature graphical element and the primary region 220 defines a distance206. In other words, the distance 206 may extend from a process featuregraphical element to the primary region 220 when the process featuregraphical element is configured in the inactive state. Conversely, whenthe process feature graphical element is configured in the active state,the distance 206 may not exist or may extend for less length than whenthe process feature graphical element was in the inactive state.

More specifically, as shown in FIG. 3A, the blood process featuregraphical element 212 is separated from the primary region 220 by space207, which indicates that the blood process feature graphical element212 is configured in an inactive state. In turn, the blood processfeature graphical element 212 being configured in an inactive state mayindicate to a user that one or more blood-related process features areinactive. For example, the blood-related process feature (e.g., a bloodcircuit-related process feature) may be the blood circuit connection, orcoupling, status, and the inactive state of the blood process featuregraphical element 212 may indicate that the blood circuit is notconnected (e.g., properly or fully connected) to the extracorporealblood treatment system for priming prior to treatment. For instance, achange in the state of the blood-related process feature correspondingto the blood process feature graphical element 212 being moved proximatethe primary graphical region 220 may include the blood circuit beingoperatively coupled to the remainder of the extracorporeal bloodtreatment apparatus for use in performing an extracorporeal bloodtreatment. Further, a change in the state of the blood-related processfeature corresponding to the blood process feature graphical element 212being moved away from the primary graphical region 220 may include theblood circuit being operatively uncoupled, or disconnected, from theremainder of the extracorporeal blood treatment apparatus, e.g., after atreatment has been completed.

Further, the dialysate process feature graphical element 214 isseparated from the primary region 220 by space 207 and by distance 206,which indicates that the dialysate process feature graphical element 214is configured in an inactive state. In turn, the dialysate processfeature graphical element 214 being configured in an inactive state mayindicate to a user that one or more dialysate-related process featuresare inactive. For example, the dialysate-related process feature (e.g.,dialysate circuit-related process feature) may be dialysate circuit/lineconnection status, and the inactive state of the dialysate processfeature graphical element 214 may indicate that the dialysate circuit isnot connected (e.g., properly or fully connected) to the extracorporealblood treatment system for priming prior to treatment. Further, forexample, the dialysate-related process feature (e.g., dialysatecircuit-related process feature) may be dialysate circuit operativecoupling status, and the inactive state of the dialysate process featuregraphical element 214 may indicate that the dialysate circuit is notoperatively coupled, or connected, to the remainder of theextracorporeal blood treatment apparatus such as to the blood circuit soto be able to perform a blood treatment on the blood circulating in theblood circuit. For instance, moving the dialysate process featuregraphical element 214 away from the primary graphical region 220 (whenthe dialysate process feature graphical element 214 is proximate theprimary graphical region 220 during an ongoing blood treatment) mayplace an ongoing extracorporeal blood treatment into bypass andoperatively uncouple the dialysate circuit from the remainder of theextracorporeal blood treatment apparatus.

Still further, the ultrafiltration process feature graphical element 216is separated from the primary region 220 by space 207, which indicatesthat the ultrafiltration process feature graphical element 216 isconfigured in an inactive state. In turn, the ultrafiltration processfeature graphical element 216 being configured in an inactive state mayindicate to a user that one or more ultrafiltration-related processfeatures are inactive. For example, the ultrafiltration-related processfeature may be ultrafiltration status, and the inactive state of theultrafiltration process feature graphical element 216 may indicate thatultrafiltration is not being performed by the extracorporeal bloodtreatment system during a treatment. Conversely, the active state of theultrafiltration process feature graphical element 216, when theultrafiltration process feature graphical element 216 is locatedproximate the primary region 220 and/or the other process featuregraphical elements 212, 214, may indicate that ultrafiltration is beingperformed by the extracorporeal blood treatment system during atreatment. In other words, movement of the ultrafiltration processfeature graphical element 216 may initiate or stop an ultrafiltrationprocess of an ongoing extracorporeal blood treatment.

Additionally, as opposed to process feature graphical elements 212, 214,216 being described with respect to the primary region 220, theplurality of process feature graphical elements may be further spatiallydescribed with respect to each other. For example, the plurality ofprocess feature graphical elements 212, 214, 216 may also be separatedfrom each other by space 209, which may indicate that the processfeature graphical elements 212, 214, 216 are configured in an inactive,or latent, state. Conversely, for example, the plurality of processfeature graphical elements 212, 214, 216 may not be separated from eachother by space 209 or at least less space 209 than when configured inthe inactive state, which may indicate that the process featuregraphical elements are configured in an active, or executing, state.

Further, the process feature graphical elements with respect each otherand/or viewed as a whole may provide additional information to the userregarding the associated process features and/or the overall, orprimary, process associated with each of the process features. Forexample, at least some of the plurality of process feature graphicalelements may be configured (e.g., shaped, sized, positioned, etc.) toform a user-recognizable form, or shape, when the process featuregraphical elements are located proximate each other (e.g., not separatedby 207 or distance 206, still separated by some space but located closedto each other than shown in FIG. 3A, etc.). The user-recognizable form,or shape, may be described as any shape recognizable by a user using theexemplary graphical user interface 200. Further, the completed,user-recognizable form, or shape, may be described as being only theperimeter of the shape or form (e.g., items inside of the perimeter maybe inconsequential to the completed form, or shape). In the examplesdepicted in FIGS. 3-5, the user-recognizable form is a circle. In otherexamples such as shown in FIG. 6, the user-recognizable form may be asquare or triangle. In one or more embodiments, the user-recognizableform may be described as being “seamless” when complete.

It may be further described that, when the plurality of process featuregraphical elements are moved together, or dragged-and-connected to eachother, (e.g., in conjunction with, or at the same time as, the pluralityof process feature graphical elements 212, 214, 216 being movedproximate the primary region 220) to form a user-recognizable form, theplurality of process feature graphical elements may become, or create, amore harmonious, or congruous, shape, which may indicate that anoverall, or primary, process associated with each of the processfeatures of the process feature graphical elements 212, 214, 216 isready to be performed or is being performed as will be described furtherherein with respect to FIGS. 4A-4L. In one or more embodiments, themovement (e.g., drag-and-connect) of the plurality of process featuregraphical elements 212, 214, 216 to form a user-recognizable form orshape may indicate that a prescription has been completed for atreatment. In other words, a complete, user-recognizable form of thegraphical user elements may indicate that all components of aprescription have been added to the treatment to fulfil theprescription. It may be described that a prescription includes, e.g.,one or more parameters set, or programmed, by a user typically that maybe identified by a patient identification number or similar. Further,the prescription may described as include all, or at least a portion, ofthe parameters and settings for carrying out, or performing, atreatment.

The blood process feature graphical element 212 has been movedproximate, or dragged-and-connected to, the primary region 220 as shownin FIG. 3B. Each of the process feature graphical elements may either bemoved, or dragged-and-connected, by a user, e.g., to indicate that oneor more process features associated therewith are initiated, resumed, orcompleted, to initiate, or start, one or more processes associated withthe process feature graphical element, etc., or moved automatically bythe treatment system, e.g., in response to one or more process featuresassociated with the process feature graphical element initiating, one ormore process features associated with the process feature graphicalelement completing, etc. In the example depicted in FIGS. 3A-3B, a usermay move the blood process feature graphical element 212 towards alocation proximate the primary region 220 to indicate that the bloodline or circuit has been coupled, or connected, to the treatment systemand configured such that the blood line or circuit is ready for priming.In other examples, the blood process feature graphical element 212 maybe automatically moved towards a location proximate the primary region220 by the system to indicate that the blood line or circuit has beenproperly coupled, or connected, to the treatment system (e.g., and thelid of the machine has been “closed”) and configured such that the bloodline or circuit is ready for priming.

The movement, or drag-and-connection, of the process feature graphicalelements 212, 214, 216 with respect to each other and the primary region220 may be further described in terms of “connection areas.” Forexample, each of the process feature graphical elements 212, 214, 216and the primary region 220 may define one or more connection areas. Eachconnection area may correspond to a different process feature graphicalelement of the one or more process feature graphical elements 212, 214,216 and/or the primary region 220. A connection area may be defined asthe area, or portion, of the process feature graphical element orprimary region that is configured to be proximate, touching, oroverlapping with a connection area of another process feature graphicalelement or primary region when configured in a state such as, e.g., anactive state.

For example, the blood process feature graphical element 212 may definea connection area 270 and the primary region 220 may define a connectionarea 272. When the blood process feature graphical element 212 is movedproximate the primary region 220 as shown in the FIG. 3B, the connectionareas 270, 272 of the blood process feature graphical element 212 andthe primary region 220 (e.g., at or near the perimeter thereof),respectively, may be located proximate (e.g., adjacent, in contact,touching, closer to, etc.) each other to, e.g., indicate that the bloodcircuit or lines is coupled to the treatment system.

The operation region 201 may further include one or more affordances toindicate to a user where the process feature graphical elements may bemoved to or away from. For example, as shown in FIG. 3B, an affordanceindication 230 is depicted indicating where the blood process featuregraphical element 212 (e.g., presently representing the blood circuit)had been moved from when configured in the inactive state as shown inFIG. 3A to indicate to a user that the blood process feature graphicalelement 212 may be moved back to the previous location proximate theaffordance indication 230 (to, e.g., move the blood process featuregraphical element 212 back to the inactive state). The affordanceindication 230 may be further referred to as a “docking line” where theprocess feature graphical elements may be docked, or parked, when in aninactive state.

Further, while a process feature graphical element is being moved eitherto the primary region 220 or away from the primary region 220 towardsthe affordance indication 230, one or more affordances may be providedto indicate where the process feature graphical element may be moved to.For example, as shown in FIG. 3C, a movement affordance indication 232may be displayed when a user selects the dialysate process featuregraphical element 214 to move towards the primary region 220. Themovement affordance indication 232 may include one or more graphicalindications and/or animations to indicate where the dialysate processfeature graphical element 214 may be moved to. As shown in this example,the movement affordance indication 232 may include slanted-linehighlighting extending between the dialysate process feature graphicalelement 214 and the primary region 220, which may indicate that thedialysate process feature graphical element 214 may be moved towards andproximate to the primary region 220 to, e.g., place or configure thedialysate process feature graphical element 214 in the active state.When the dialysate-related process feature (e.g., dialysatecircuit-related process feature) is the dialysate line connectionstatus, the active state of the dialysate process feature graphicalelement 214 may indicate that the dialysate circuit is connected (e.g.,properly or fully connected) to the extracorporeal blood treatmentsystem for priming prior to treatment. When the dialysate-relatedprocess feature (e.g., dialysate circuit-related process feature) is thedialysate circuit operative coupling status, the active state of thedialysate process feature graphical element 214 may indicate that thedialysate circuit is operatively coupled, or connected, to theextracorporeal blood treatment apparatus such as to the blood circuit soto be able to perform a blood treatment on the blood circulating in theblood circuit.

The movement affordance indication 232 may also indicate that thedialysate process feature graphical element 214 may be moved back to theaffordance indication 230 to place, or configure, the dialysate processfeature graphical element 214 in the inactive state while the dialysateprocess feature graphical element is being moved as shown in FIG. 3D.Additionally, although not shown in FIGS. 3C-3D, the movement affordanceindication 232 may be shown on both sides of the dialysate processfeature graphical element 214 when the dialysate process featuregraphical element 214 is being moved and located between the primaryregion 220 and the affordance indication 230 (e.g., the movementaffordance indication 232 may extend between both the dialysate processfeature graphical element 214 and the primary region 220 and thedialysate process feature graphical element 214 and the affordanceindication 230).

The dialysate process feature graphical element 214 has been moved(e.g., automatically moved by the system) proximate to the primaryregion 220 in FIG. 3D. In the example depicted in FIGS. 3A-3D, thetreatment system may automatically move the dialysate process featuregraphical element 214 towards a location proximate the primary region220 to indicate that the dialysate line and/or circuit has been coupledto the system and configured such that the dialysate line or circuit isready for priming (e.g., sensed or detected using one or more fluidcircuit sensors, etc.). Further, a user may move (e.g., drag andconnect) the dialysate process feature graphical element 214 towards alocation proximate the primary region 220 to indicate that the dialysateline or circuit has been coupled to the system and configured such thatthe dialysate line and/or circuit is ready for priming.

In one or more embodiments, the treatment system may automatically movethe dialysate process feature graphical element 214 towards a locationproximate the primary region 220 to indicate that the dialysate lineand/or circuit has been operatively coupled to the blood circuit andconfigured to perform a blood treatment on the blood circulating in theblood circuit (e.g., remove waste from the blood circulating in theblood circuit). Further, a user may move (e.g., drag and connect) thedialysate process feature graphical element 214 towards a locationproximate the primary region 220 to operatively couple the dialysateline or circuit to the blood circuit and configured to perform a bloodtreatment on the blood circulating in the blood circuit (e.g., removewaste from the blood circulating in the blood circuit). In other words,movement of the dialysate process feature graphical element 214 mayinitiate or stop a blood treatment process of an extracorporeal bloodtreatment using the dialysate circuit.

After the blood process feature graphical element 212 and the dialysateprocess feature graphical element 214 have been moved proximate theprimary region 220, each of the blood circuit and the dialysate circuitof the treatment system may be indicated as being ready for priming. Inone or more embodiments, the treatment system may automatically beginpriming once the blood process feature graphical element 212 and thedialysate process feature graphical element 214 have been movedproximate the primary region 220. Further, in one or more embodiments, auser may select an element, region, or area of the graphical userinterface 200 to initiate priming. For example, the primary region 220may be selectable to initiate or cease one or more processes, and in atleast one example, may be selectable to initiate priming. In theembodiment depicted, however, the priming is configured to “Auto Start”upon the blood process feature graphical element 212 and the dialysateprocess feature graphical element 214 having been automatically movedproximate the primary region 220 and upon the detection of the bloodcircuit and dialysate circuit being properly physically attached to thetreatment system. Thus, the treatment system may be described as beingconfigured to self-initiate upon the detection of the blood circuit anddialysate circuit being properly physically attached, or coupled, to thetreatment system.

Nonetheless, the primary region 220 may act as a button for one or moreprocesses and/or process features. For example, the primary region 220may be selectable to start, or initiate, the primary, or overall,process associated with or corresponding to the process features of theprocess feature graphical elements. For example, as shown in FIGS.3A-3I, at least some of the process feature graphical elements areassociated with hemodialysis setup and priming, and thus, the primaryregion 220 may be selectable to initiate or cease one or more processesof the hemodialysis setup and priming.

Further, the primary region 220 may include an alphanumeric indication222 with respect to the operation of the primary region 220 as well asthe overall, or primary, process. In this example, the priming isconfigured to automatically start, and thus, the alphanumeric indication222 recites “AUTO START,” which indicates that a priming process willautomatically start, or initiate, once the treatment system is setup andready for priming (e.g., the blood process feature graphical element 212and the dialysate process feature graphical element 214 have been movedproximate the primary region 220, the detection of the blood circuit anddialysate circuit being properly physically attached to the treatmentmachine has occurred, etc.). In one or more embodiments, if the systemis primed with a saline fluid, the dialysate process feature graphicalelement 214 may not need to be connected to the primary region 220before priming.

After the blood circuit and the dialysate circuit have begun priming,one or more graphical animations may be displayed on and/or between theprocess feature graphical elements associated with and representing theprocess features related to the blood circuit and dialysate circuitpriming. For example, a fluidic progress bar may be displayed in theprocess feature graphical elements to indicate progression of primingeach of the process features associated therewith. As shown in FIG. 3E,a fluidic progress bar 234 may be displayed in the blood process featuregraphical element 212 to indicate progression of priming of the bloodcircuit.

Further, for example, a fluidic animation may be displayed betweenprocess feature graphical elements to indicate one or more processesoccurring between the process features associated therewith. As shown inFIG. 3E, a fluidic animation 236 may be displayed in the blood processfeature graphical element 212 and the dialysate process featuregraphical element 214 to indicate that priming is occurring in and/orbetween the blood circuit and the dialysate circuit. The fluidicanimation 236 may include graphical representations of a flow ofparticles such as bubbles and/or fluid particles exchanging, or moving,within and/or between the blood process feature graphical element 212and the dialysate process feature graphical element 214. Further, thefluidic animation 236 may be described as graphically indicatingconnection of the blood process feature graphical element 212 and thedialysate process feature graphical element 214 and/or the operablecoupling of apparatus and/or devices associated with the blood processfeature graphical element 212 and the dialysate process featuregraphical element 214 such as a blood circuit and dialysate circuit,respectively, through a dialyzer or filter.

During priming, the primary region 220 may include the alphanumericindication “STOP Priming” to indicate to a user that the user may selectthe primary region 220 to cease, or stop, the priming process. As shownin FIG. 3F, the fluidic progress bar 234 may indicate a completedprocess when the blood circuit is primed.

Once the priming process is complete, the fluidic animation 236 may notbe shown (e.g., the fluidic animation 236 may stop or cease) as shown inthe exemplary graphical user interface 202 of FIG. 4A. The exemplarygraphical user interface 202 of FIG. 4A-4L may be configured for use inperforming a treatment using an extracorporeal blood treatment system,e.g., after setup and priming has been completed using the exemplarygraphical user interface 200 as shown in FIGS. 3A-3F.

The exemplary graphical user interface 202 of FIG. 4A-4L may include anoperation region 201 and further include the same or similar processfeature graphical elements as the exemplary graphical user interface 200of FIGS. 3A-3F. For example, the exemplary graphical user interface 202may include an operation region 201 and a plurality of process featuregraphical elements such as, e.g., process feature graphical elements212, 214, 216.

Further, the exemplary graphical user interface 202 may include ahuman-shaped process feature graphical element 218 that is associatedwith and representative of the actual patient to be treated by theextracorporeal blood treatment system. As shown, the human-shapedprocess feature graphical element 218 may define a diagrammatic, orsymbolic, representation of a human body. The human-shaped processfeature graphical element 218 may define an outline, or perimeter, ofthe human body, or form, including a plurality of body parts or portionssuch as, e.g., two arms, two legs, a torso, a head, a neck, etc. Asshown, the human-shaped process feature graphical element 218 appears tobe in a standing or prone position. Further, the human-shaped processfeature graphical element 218 may be recognizable by a user to representthe human patient to be treated by the system.

The human-shaped process feature graphical element 218 may furtherinclude one or more features, areas, and/or elements to indicate one ormore blood-related parameters of the patient. For example, thehuman-shaped process feature graphical element 218 may include a bloodpressure indication 224 that indicates the patient's present, or lastmeasured, blood pressure value (e.g., as shown, 144 systolic over 70diastolic) and a heart-shaped graphical element, or heart rateindication, 226 may indicate and/or initiate one or more processfeatures related to a patient. The heart-shaped graphical element 226may be described as being proximate the human-shaped process featuregraphical element 218. In at least one embodiment, such as shown, theheart-shaped graphical element 226 may be located within the humanoutline of the human-shaped process feature graphical element 218. Inother embodiments, the heart-shaped graphical element 226 may bepartially located within or outside of the human outline of thehuman-shaped process feature graphical element 218.

The heart-shaped graphical element 226 may pulsate to indicate that thepatient's heart rate and/or blood pressure is being presently measured.Further, a pulse or echocardiograph line graphically depicted with, orproximate, the heart-shaped graphical element 226 may be animated toindicate that the patient's heart rate and/or blood pressure is beingpresently measured. Further, the human-shaped process feature graphicalelement 218 may include additional graphical areas or regions configuredto be selectable by a user to access (e.g., display) one or more patientrecords or settings for review and/or edit by a user.

The human-shaped process feature graphical element 218 may be selectable(e.g., touchable, clickable, etc.) to display a patient informationregion on, or over, at least a portion of the graphical user interface202. The patient information region may include patient-relatedinformation. The patient-related information may include one or moreitems of information related to the patient such as, e.g., the patient'streatment history, the patient's medical condition history, a treatmentsummary, notes about the patient, the patient's medical records, thepatient's prescription, the patient's treatment schedule, the patient'sprescribed or un-prescribed medication, the patient's contactinformation, pre- and post-treatment data such as vital signs, patientappearance, patient comfort level, the patient's treatment report, etc.Further, a user may use the patient information region to edit one ormore pieces of information displayed thereon.

Further, one or more regions, areas, or elements of the human-shapedprocess feature graphical element 218 may be selectable (e.g.,touchable, clickable, etc.) to activate, or initiate, various actions orprocesses corresponding to, or related to, the patient (and related to,e.g., the blood pressure indication 224, the heart rate indication 226).For example, heart rate indication, or heart-shaped graphical element,226 (e.g., the shape in the form of a heart), or another area of thehuman-shaped process feature graphical element 218, may be selectable bya user to initiate a blood pressure measurement of the patient. Afterthe blood pressure measurement is performed, the blood pressure value ofthe blood pressure indication 224 may be updated (e.g., display themeasured blood pressure values). Additionally, after a user hasinitiated a blood pressure measurement, e.g., by selecting theheart-shaped graphical element 226, the blood pressure indication 224may be “cleared” of any previous blood pressure values (e.g., systolicand diastolic blood pressure values) such that user may visualize that ablood pressure measurement is presently occurring and not be confused byprevious blood pressure values displayed in the blood pressureindication 224. For instance, the blood pressure values may be replacedby hyphens (“-”), en-dashes (“‥”), or em-dashes (“—”) in response to theinitiation of a blood pressure measurement. Further, for example, theheart-shaped graphical element 226 (e.g., the shape in the form of aheart), or another area of the human-shaped process feature graphicalelement 218, may be selectable by a user to initiate a heart ratemeasurement of the patient, and the value of measured heart rate mayalso be displayed after measurement. Also, as shown, the heart-shapedgraphical element 226 of the human-shaped process feature graphicalelement 218 may be described as being located in the approximately, orabout, the correct, or proper, anatomic location within the human formof the human-shaped process feature graphical element 218.

The human-shaped process feature graphical element 218 may furtherinclude waste graphical indicia 228 to indicate the amount of waste tobe removed from the patient (e.g., monitored or measured using one ormore sensors 142). The waste graphical indicia 228 may be defined by afill color within the outline of the human of the human-shaped processfeature graphical element 218, and as waste is removed from the patient,the fill color may be removed from within the human outline to indicateprogression of the waste removal. In other words, the waste graphicalindicia 228 within the human-shaped process feature graphical element218 may be described as representing a waste-filled container from whichthe waste “drains” as the patient is treated. As shown in FIG. 4A, nowaste has been removed from the patient since the treatment as notbegun, and thus, the waste graphical indicia 228 indicates that no wastehas been removed from the patient (e.g., the human-shaped processfeature graphical element 218 is depicted as being full of waste). Thewaste graphical indicia 228 may be a “motivator” to the patient toassist the patient in understanding the treatment and the importance ofstaying through the entire treatment (e.g., if “yellow” waste remains inthe human-shaped process feature graphical element 218, then the patientmay see, or visualize, that the treatment has not completed).Additionally, the waste graphical indicia 228 may effectivelycommunicate to the patient the progress of the treatment (e.g., suchthat the patient may determine, or gauge, how long treatment may take).

Additionally, the human-shaped process feature graphical element 218 mayinclude a graphical facial expression 229 configured to indicatehappiness when an extracorporeal blood treatment is complete (e.g.,waste has been removed from the patient, etc.). As shown in FIG. 4A, nowaste has been removed from the patient since the treatment has notbegun, and thus, the graphical facial expression 229 does not indicatehappiness. Instead, the graphical facial expression 229 appears neutral.Further, the graphical facial expression 229, or at least head portionof the human-shaped process feature graphical element 218, may beselectable by a user for documenting, editing, and/or reviewing apatient's physiological (e.g., vital signs, appearance, etc.) and/orpsychological condition (e.g., mood) in a patient report graphicalregion.

The alphanumeric indication 222 of the primary region 220 may includethe text “CONTINUE PRIMING OR CONNECT PATIENT,” which indicates to auser that priming may be continued by, e.g., selecting the primaryregion 220, or the patient may be connected to the blood circuit forperformance of the treatment. To indicate the next step, a patientconnection affordance 238 may be provided extending between the bloodprocess feature graphical element 212 and the human-shaped processfeature graphical element 218 to, e.g., indicate that the next step, ortask, is to physically connect the patient to the treatment system. Thehuman-shaped process feature graphical element 218 may automaticallymove proximate the blood process feature graphical element 212 uponphysical connection of the patient to the blood circuit (e.g., one ormore sensors or other apparatus of the treatment system may determinethat the patient has been physically connected to the blood circuit)and/or a user may move the human-shaped process feature graphicalelement 218 proximate to the blood process feature graphical element 212after physical connection of the patient to the blood circuit toindicate that the patient is properly physically connected to the bloodcircuit for treatment.

After the human-shaped process feature graphical element 218 is movedproximate the blood process feature graphical element 212 as shown inFIG. 4B, the treatment may be started. As shown, the alphanumericindication 222 of the primary region 220 may include the text “STARTBlood Pump,” which indicates to a user that the blood pump may bestarted to begin filling the blood circuit with the patient's bloodprior to treatment, e.g., by selecting the primary region 220.Additionally, the primary region 220 may be graphically animated (e.g.,flashing, highlighted, pulsing, etc.) to indicate to a user that theblood pump may be started to begin filling the blood circuit with thepatient's blood prior to treatment, e.g., by selecting the primaryregion 220. During the operation of the blood pump, the primary region220 may include a graphical animation of a blood pump running (e.g., asymbolic or graphical representation of a peristaltic pump rotating suchas two dots orbiting a center point as shown in FIG. 4K). Further, aconnection outline 240 may be depicted about the human-shaped processfeature graphical element 218 and at least a portion of the bloodprocess feature graphical element 212 after the human-shaped processfeature graphical element 218 is moved proximate the blood processfeature graphical element 212 to, e.g., indicate the physical couplingtherebetween. In other words, the connection outline 240 maysymbolically represent the connection of the patient to the bloodcircuit of the treatment system. Still further, the connection outline240 as shown in FIG. 4B may include a pair, or two, connection linesextending between the human-shaped process feature graphical element 218and the blood process feature graphical element 212 to graphicallyrepresent a venous blood line and an arterial blood line operativelycoupling a patient to a blood circuit (e.g., a disposable element 140)of the extracorporeal blood treatment system. Additionally, in exemplarysystems utilizing a single blood line operatively coupling a patient toa blood circuit, the connection outline 240 may include a singleconnection line extending from the human-shaped process featuregraphical element 218 that splits, or forks, into two connection linesbefore contacting the blood process feature graphical element 212 tographically represent such operatively coupling of a patient to a bloodcircuit (e.g., a disposable element 140) of the extracorporeal bloodtreatment system as shown in FIG. 4L.

As shown in FIG. 4A, the blood process feature graphical element 212 maydepict, or include, the alphanumeric text describing the blood processfeature graphical element 212 as being the “Blood Line.” After movementof the human-shaped process feature graphical element 218 proximate theblood process feature graphical element 212 as shown in FIG. 4B, thealphanumeric text describing the blood process feature graphical element212 may change (e.g., automatically) to “QB,” which is indicative ofblood flow rate.

Each of the process feature graphical elements may include one or moreparameters related the process features associated therewith. Forexample, the process feature graphical elements may include flow rates,volumes, pressures, temperatures, dosages, prescription parameters,times, etc. As shown, for example, the blood process feature graphicalelement 212 may include blood flow rate 213, the dialysate processfeature graphical element 214 may include dialysate flow rate 215, andthe ultrafiltration process feature graphical element 216 may includethe ultrafiltration rate 217.

Each of the process feature graphical elements may be selectable todisplay an adjustment region configured for a user to adjust one or moreparameters associated therewith. For example, if the ultrafiltrationprocess feature graphical element 216 is selected, an adjustment region219 depicted in FIG. 9 may be displayed over the entire or a portion ofthe graphical user interface 200 such that, e.g., a user may use thevarious sliders, switches, bars, etc. to adjust one or more parametersassociated with the ultrafiltration process.

As described herein, the blood pump may be started by selecting theprimary region 220 to begin filling the blood circuit with the patient'sblood. Once the blood pump has started as shown in FIG. 4C, thealphanumeric indication 222 of the primary region 220 may include thetext “STOP Blood Pump,” which indicates to a user that the blood pumpmay be stopped, e.g., by selecting the primary region 220. Additionally,the primary region 220 may be graphically animated (e.g., flashing,highlighted, pulsing, etc.) to indicate to a user that the blood pumpmay be stopped. Further, after the blood pump is started, a fluidicprogress bar 234 may be displayed in the blood process feature graphicalelement 212 to indicate progression of blood filling the blood circuit.

After blood has filled the circuit as shown in FIG. 4D, the alphanumericindication 222 of the primary region 220 may include the text “STARTBlood Pump,” which indicates to a user that the blood pump may bestarted to begin the treatment, e.g., by selecting the primary region220. Additionally, the primary region 220 may be graphically animated(e.g., flashing, highlighted, pulsing, etc.) to indicate to a user thatthe blood pump may be started to begin treatment, e.g., by selecting theprimary region 220.

Further, an anticoagulation process feature graphical element 242 may befurther depicted in the operation region 201 that may be associated withand representative of the anticoagulation provided by the treatmentsystem. Similar to other process feature graphical elements describedherein, the anticoagulation process feature graphical element 242 may bemoved proximate another process feature graphical element, such as theblood process feature graphical element 212 to indicate the delivery ofanticoagulation to the blood circuit. In this example, theanticoagulation process feature graphical element 242 represents and isassociated with heparin. In other embodiments, one or more processfeature graphical elements similar to the anticoagulation processfeature graphical element 242 may be associated with and representativeof other process features such as, e.g., natrium/sodium profilingproximate to the dialysate process feature graphical element 214,ultrafiltration profiling proximate to the ultrafiltration processfeature graphical element 216, etc.

In one or more embodiments, process feature graphical elements such asthe anticoagulation process feature graphical element 242 may bereferred to as secondary process feature graphical elements because,e.g., such process feature graphical elements may not contribute to theformation, or completion, of a user-recognizable form. Instead, it maybe described that the secondary process feature graphical element may be“clipped” or “attached” to another process feature graphical elementthat contributes to, or may be part of, a user-recognizable form.Further, the secondary process feature graphical element may affect oneor more parameters and/or processes associated with and represented bythe process feature graphical element the secondary process featuregraphical element is attached. For example, the anticoagulation processfeature graphical element 242 may be coupled to the blood processfeature graphical element 212, and thus, may provide one or more processfeatures that have at least some effect on the processes associated withand represented by the blood process feature graphical element 212.Still further, the secondary process feature graphical element may bedescribed as being tied to, or “running with,” the process featuregraphical element it is coupled to. In other words, the secondaryprocess feature graphical element may behave and be interacted with inthe same way as the process feature graphical element it is coupled to.For example, if a process feature graphical element is activated ordeactivated (e.g., by selecting-and-moving it away or proximate toanother graphical element), an attached secondary process featuregraphical element may also be activated or deactivated, respectively.For example, if the blood process feature graphical element 212 is movedaway from the primary region 220 and/or other process feature graphicalelements, the anticoagulation process feature graphical element 242 mayremain coupled to the blood process feature graphical element 212 andmove with the blood process feature graphical element 212 away from theprimary region 220 and/or other process feature graphical elements,which may affect the one or more processes associated withanticoagulation process feature graphical element 242 (e.g., deactivateanticoagulation processes, etc.). In this way, a user may only need toselect-and-drag the blood process feature graphical element 212 tosimultaneously affect the anticoagulation process feature graphicalelement 242.

As shown in FIG. 4E, the anticoagulation process feature graphicalelement 242 has been moved proximate the blood process feature graphicalelement 212 to, e.g., indicate that the anticoagulation is beingdelivered into the blood circuit, indicate that the anticoagulation iscoupled to the blood circuit and ready for delivery into blood circuit,etc. Similar to other process feature graphical elements, theanticoagulation process feature graphical element 242 may be moved by auser to indicate that the anticoagulation should begin or that theanticoagulation is coupled to the system, or may be moved automaticallyby the system in response to the anticoagulation being connected to theblood circuit. Further, similar to other process feature graphicalelements, an affordance indication 230 may be depicted indicating wherethe anticoagulation process feature graphical element 242 has been movedfrom when in the inactive state to indicate to a user that theanticoagulation process feature graphical element 242 may be moved backto the previous location proximate the affordance indication 230 (to,e.g., move the anticoagulation process feature graphical element 242back to an inactive state). In one or more embodiments, when processfeature graphical elements and the process features associated therewithare deactivated, or configured in an inactive state, the process featuregraphical elements may be graphically animated, e.g., by flashing,highlighting, etc., to signal to a user that such process features arecurrently in a deactivated state.

Further, the blood pump has been started in FIG. 4E and a fluidicanimation 236 may be displayed in the blood process feature graphicalelement 212 and the dialysate process feature graphical element 214 toindicate that flow is occurring in each of the blood circuit and thedialysate circuit of the treatment system.

In at least the embodiment depicted herein, movement indicators, oraffordances, 241 may be displayed proximate the process featuregraphical elements to indicate that the process feature graphicalelements may be moved and the direction where such process featuregraphical elements may be moved. The movement indicators 241 as shownare a pair of short parallel lines located, or depicted, on the side ofthe process feature graphical element where it may be moved to. Forexample, a movement indicator 241 is shown proximate the dialysateprocess feature graphical element 214 to indicate that it may be movedaway from the primary graphical region 220 and/or other process featuregraphical elements such as blood process feature graphical element 212.Likewise the movement indicator 241 proximate the dialysate processfeature graphical element 214 is not located between the dialysateprocess feature graphical element 214 and the primary graphical region220 and the blood process feature graphical element 212. Conversely, forexample, a movement indicator 241 is shown proximate the ultrafiltrationprocess feature graphical element 216 to indicate that it may be movedtowards and proximate the primary graphical region 220 and/or the otherprocess feature graphical elements 212, 214. Likewise the movementindicator 241 proximate the ultrafiltration process feature graphicalelement 216 is generally located between the ultrafiltration processfeature graphical element 216 and the primary graphical region 220 andthe other process feature graphical elements 212, 214.

To begin ultrafiltration, the ultrafiltration process feature graphicalelement 216 may be moved proximate the primary region 220 as shown inFIG. 4F. It may be described that the ultrafiltration process featuregraphical element 216 may be moved proximate the blood process featuregraphical element 212 and the dialysate process feature graphicalelement 214 to complete the user-recognizable form, or shape, 250, whichin this example is a circle. Completion of the user-recognizable form250 may indicate to a user that a prescription for the blood treatmenttherapy is complete. Further, completion of the user-recognizable form250 may indicate to a user that no more processes or steps need to beperformed until to completion of treatment (e.g., the completion of theuser-recognizable form 250 may indicate that all of the processes orsteps for the prescribed treatment have been completed). Further, whenthe graphical user interface includes one or more secondary processfeature graphical elements, the complete prescription may not becompleted until the one or more secondary process feature graphicalelements are also moved proximate the user-recognizable form 250 (e.g.,even if the secondary process feature graphical elements do not formpart of the user-recognizable form 250). Additionally, a movementindicator 241 is now shown proximate the ultrafiltration process featuregraphical element 216 to indicate that it may be moved away from theprimary graphical region 220 and/or other process feature graphicalelements such as blood process feature graphical element 212 anddialysate process feature graphical element 214.

As treatment continues, waste may be removed from the patient asindicated by the waste graphical indicia 228 of the human-shaped processfeature graphical element 218 as shown in FIG. 4G. More specifically, atleast some of the fill color representing the waste within the humanoutline may have disappeared. Further, it may be described that thewaste graphical indicia 228, e.g., the fill color, defines a waste fluidlevel line, e.g., symbolically representing a fluid level of the wasteleft in a waste-filled container. In other words, the waste may be shownto be partially removed by the graphical indicia 228 in the human-shapedprocess feature graphical element 218 of FIG. 4G. Also, a fluidicanimation 236 may be displayed in the blood process feature graphicalelement 212 and the ultrafiltration process feature graphical element216 to indicate that flow is occurring in the blood circuit and theultrafiltration apparatus.

After the treatment is completed, the waste graphical indicia 228 of thehuman-shaped process feature graphical element 218 may indicate thatall, or at least a selected value of, waste has been removed from thepatient and the graphical facial expression 229 of the human-shapedprocess feature graphical element 218 may be configured to showhappiness to indicate that extracorporeal blood treatment is completeand that the patient disconnection procedures including rinseback maybegin as shown in FIG. 4H. To begin rinseback, as user may select theprimary region 220, which may include the alphanumeric indication 222,“START Rinseback” and/or be graphically animated.

After rinseback is complete, a patient disconnection affordance 239 asshown in FIG. 4I may be provided extending between the blood processfeature graphical element 212 and the human-shaped process featuregraphical element 218 to, e.g., indicate that the next step, or task,may be to physically disconnect the patient from the treatment system.The human-shaped process feature graphical element 218 may automaticallybe moved away from the blood process feature graphical element 212 uponphysical disconnection of the patient from the blood circuit (e.g., oneor more sensors or other apparatus of the treatment system may determinethat the patient has been physically disconnected to the blood circuit)and/or a user may move the human-shaped process feature graphicalelement 218 away from the blood process feature graphical element 212after physical disconnection of the patient from the blood circuit toindicate that the patient is properly physically disconnected from theblood circuit after treatment. Additionally, although not depicted, afluidic progress bar may be displayed in the blood process featuregraphical element 212 to indicate progression of the rinseback of theblood circuit. Further, as shown in FIG. 4J, one or more confirmationgraphical regions or areas may be presented during the disconnectionprocess. For example, if a user had selected the human-shaped processfeature graphical element 218 and moved, or dragged, the human-shapedprocess feature graphical element 218 away from the blood processfeature graphical element 212, a confirmation graphical region 260 maybe displayed, or depicted, to confirm that the patient is actually,physically, disconnected. The confirmation graphical region 260 mayinclude a query asking the user whether the patient is physicallydisconnected from the blood circuit. The confirmation graphical region260 may further allow a user to answer affirmatively or negatively tothe query. In the embodiment shown, to confirm that the patient isactually, physically, disconnected, a user may select an area or elementof the confirmation region. For example, a user may select a “NO”graphical area 262 to indicate to the treatment system that the patientis not physically disconnected from the blood line, which in turn, willremove the confirmation graphical region 260 from the graphical userinterface 202 returning to the graphical user interface 202 shown inFIG. 4I with the human-shaped process feature graphical 218 proximatethe blood process feature graphical element 212. In other words, inresponse to the user answering the query negatively, the human-shapedgraphical element may be moved (back to being) proximate the bloodprocess feature graphical element 212). Conversely, for example, a usermay select a “YES” graphical area 264 to indicate to the treatmentsystem that the patient is physically disconnected from the blood line,which in turn, will also remove the confirmation graphical region 260from the graphical user interface 202 but with the human-shaped processfeature graphical 218 moved away from the blood process featuregraphical element 212 as shown in FIG. 5A. After a patient has beendisconnected, the sensors of the treatment system should not detectblood in the blood circuit.

In one or more embodiments, the human-shaped process feature graphicalelement 218 may be integrated with or in proximity to a blood pressuregraphical representation 221 associated with the a connection outline240 including blood lines as shown in FIG. 4K between the processfeature graphical elements 212, 214, 216 and the primary region 220 andthe human-shaped process feature graphical element 218. The bloodpressure graphical representation 221 may include a graphical andnumerical representation of each of venous and arterial blood pressure,each proximate (e.g., adjacent, extending therefrom, next to, etc.) tothe respectively-related venous and arterial blood line. The graphicalrepresentations of the venous and arterial blood pressure may includehistorical graphs of pressures measured, or monitored, in the venous andarterial blood lines, respectively, from a selected point in the past(e.g., 1 minute previously, 1 minutes previously, 10 minutes previously,etc.) to the present time. The numerical representations of the venousand arterial blood pressure may be the present pressures measured, ormonitored, in the venous and arterial blood lines, respectively.

Additionally, as shown in the embodiment in FIG. 4K, the primary region220 may include a graphical representation of a pump, which may indicatewhen the pump is active (e.g., pumping, running, etc.) or inactive(e.g., not pumping, not running, etc.). As shown, the graphicalrepresentation of a pump in the primary region 220 includes two dots, orspots, configured to represent a peristaltic pump such as a the bloodpump. When the pump is active, the two dots, or spots, may rotate, ororbit, about the center of the circle of the primary region 220 asindicated by the arrows. When the pump is inactive, the two dots, orspots, may be stationary or may not be shown. Additionally, although notshown, it is be understood that the graphical representation of the pumpmay be shown, or depicted with, or in conjunction, with the alphanumericindication 222 of the primary region 220.

After the rinseback is complete and the patient is disconnected from thetreatment system, post-treatment processes using the exemplary graphicaluser interface 204 of the extracorporeal blood treatment system may beperformed such as “disinfection” as shown in FIGS. 5A-5B. Similar to theexemplary graphical user interfaces 200, 202 described herein, theexemplary graphical user interface 204 may include a plurality ofprocess feature graphical elements 212, 214, 216 and a primary region220.

As shown in FIG. 5A, the dialysate process feature graphical element 214is shown located away from the primary region 220 and away from theblood circuit and ultrafiltration process feature graphical elements212, 216 to, e.g., indicate that the dialysate circuit is not connectedto blood treatment system and/or blood circuit and ultrafiltrationapparatus. Further, the alphanumeric indication 222 of the primaryregion 220 recites “START Disinfection,” which indicates that thedisinfection process will start upon user selection of the primaryregion 220.

In FIG. 5B, the dialysate process feature graphical element 214 is shownproximate the primary region 220 and the blood circuit andultrafiltration process feature graphical elements 212, 216 to, e.g.,indicate that the dialysate circuit is connected to blood treatmentsystem and/or blood circuit and ultrafiltration apparatus. Further, thedisinfection process is being performed as may be indicated by changesto the process feature graphical elements 214, 216 (e.g., color changes,highlighting, etc.).

As described herein, the exemplary process feature graphical elementsmay form a user-recognizable form, or shape, when the process featuregraphical elements are located proximate each other such as, e.g., acircle, square, triangle, rectangle, line, hexagon, and/or any otherclearly recognizable shape. The user-recognizable form may be the samefor each different overall, or primary, process represented by theuser-recognizable form. For example, in FIGS. 3-5, the user-recognizableform is a circle for the setup and priming process depicted in FIGS.3A-3F, the blood treatment process depicted in FIGS. 4A-4L, and thedisinfection process depicted in FIGS. 5A-5B. In other embodiments, theuser-recognizable form may be different for each different overall, orprimary, process represented by the user-recognizable form. For example,three different user-recognizable forms 300, 310, 320 representative ofthree different overall, or primary, processes are depicted in FIG. 6.More specifically, the user-recognizable form 300 corresponding to asetup and priming process is a square, the user-recognizable form 310corresponding to a blood treatment process is a circle, and theuser-recognizable form 320 corresponding to a post-treatment process isa triangle.

In at least one embodiment, each of the user-recognizable forms 300,310, 320 may be displayed in an operation region of an exemplarygraphical user interface one-at-a-time. Further, the displayeduser-recognizable forms 300, 310, 320 may be selected by a user. Forexample, if the user-recognizable form 300 for setup and priming isdisplayed and a user would like the user-recognizable form 310 for bloodtreatment to be displayed, a user may perform a swipe, or swiping,gesture 311 across a portion of the graphical user interface (e.g.,touchscreen) to display the user-recognizable form 310 for bloodtreatment.

The user-recognizable form 300 associated with and representative ofsetup and priming includes four setup/priming process feature graphicalelements. More specifically, the user-recognizable form 300 may includea blood process feature graphical element 302 (e.g., representative ofand associated with the blood line), a priming process feature graphicalelement 304, a setup process feature graphical element 306 (e.g.,representative of and associated with the dialyzer/filter), and aconcentrate/cartridge process feature graphical element 308 (e.g.,representative of and associated with a concentrate and/or cartridge tobe used in priming and/or therapy). The blood process feature graphicalelement 302 may be at least partially similar to the blood processfeature graphical element 212 and the concentrate/cartridge processfeature graphical element 308 may be at least partially similar to thedialysate process feature graphical element 214 described herein withrespect to FIGS. 3-5

The user-recognizable form or shape 310 may be similar to theuser-recognizable form 250 described herein with respect to FIGS. 3-5.The user-recognizable form 320 associated with and representative ofdisinfection includes two process feature graphical elements. The bloodprocess feature graphical element 322 may be at least partially similarto the blood process feature graphical element 212 described herein withrespect to FIGS. 3-5. The heat citric disinfection process featuregraphical element 324 may be associated with and representative ofdisinfection fluid used in the disinfection process.

Another exemplary graphical user interface 400 for use in performing atreatment using an extracorporeal blood treatment system is depicted inFIGS. 7A-7C. The graphical user interface 400 may include a plurality ofprocess feature graphical elements such as a blood process featuregraphical element 412, a dialysate process feature graphical element414, and an ultrafiltration process feature graphical element 416. Tochange a state associated with a process feature of the dialysateprocess feature graphical element 414, the dialysate process featuregraphical element 414 may be moved (e.g., by dragging towards, etc.)proximate to the blood process feature graphical element 412 as shown inFIG. 7B.

In this example, rather than the entire dialysate process featuregraphical element 414 being moved proximate the blood process featuregraphical element 412, an end portion 415 of the dialysate processfeature graphical element 414 may be moved proximate the blood processfeature graphical element 412. In other words, the end portion 415 maybe moved towards and proximate the blood process feature graphicalelement 412 to extend the dialysate process feature graphical element414 into contact with, overlapping with, or in close proximity to theblood process feature graphical element 412. The end portion 415 may besimilar to the connection areas 270, 272 described herein with referenceto FIGS. 3A-3B, and the blood process feature graphical element 412 mayfurther define a connection area similar to the connection areas 270,272 described herein with reference to FIGS. 3A-3B. The end portion 415,or connection area, of the dialysate process feature graphical element414 may be moved proximate (e.g., overlapping, touching, contacting,closer to, etc.) the connection area of the blood process featuregraphical element 412 to, e.g., indicate a change in a state of thedialysate process feature graphical element 414 and/or the blood processfeature graphical element 412.

The dialysate process feature graphical element 414 being movedproximate to the blood process feature graphical element 412 mayindicate completion of the fluid coupling of the dialysate circuit andthe blood circuit. Further, as described herein, a fluidic animation 436may be displayed in the dialysate process feature graphical element 414as shown in FIG. 7B after such fluid coupling. The fluidic animation 236may include graphical representations of a flow of particles such asbubbles and/or fluid particles exchanging, or moving, in the end portion415 of the dialysate process feature graphical element 414 proximate theblood process feature graphical element 412.

The ultrafiltration process feature graphical element 416 may includesimilar functionality to the dialysate process feature graphical element414. For example, as shown in FIG. 7C, the ultrafiltration processfeature graphical element 416 may include an end portion 417 configuredto be moved proximate the blood process feature graphical element 412 toindicate the performance of ultrafiltration in a treatment.

In this example, the blood process feature graphical element 412 may bedefined or described as a graphical region of the graphical userinterface 400. Further, the blood process feature graphical element 412may be described as a stationary graphical region (e.g., a region thatdoes not, or is not allowed to, move). The blood process featuregraphical element 412 may include, or display, multiple blood-relatedparameters and/or settings. For example, as shown, the blood processfeature graphical element 412 includes an arterial pressure feature 430for displaying the current and past arterial pressure of the patient, avenous pressure feature 432 for displaying the current and past venouspressure of the patient, a treatment adequacy parameter feature 434 fordisplaying the adequacy of the treatment (e.g., Kt/v), and ananticoagulation delivery feature 435 for displaying the anticoagulationtype (e.g., heparin) and delivery rate (e.g., 13 ml/h).

In one or more embodiments, the process feature graphical elements maybe configured to overlap each other when moved proximate one another asshown in another exemplary graphical user interface 500 for use in anextracorporeal blood treatment system as depicted in FIGS. 8A-8F.

As shown, the exemplary graphical user interface 500 may include anoperation region 502 and a settings region 504. The operation region 502may include one or more process feature graphical elements. As shown inFIG. 8A, the graphical user interface 500 is configured in a primingmode, and as such, the operation region 502 includes a priming processfeature graphical element 510 corresponding to priming a fluid circuitof a treatment system. The priming process feature graphical element 510further includes the alphanumeric text, “Priming” and “4 min left” toindicate to a user that the system is priming and that an estimated timeto completion of the priming process is 4 minutes. Further, acircumferential indicator 507 may located about the circumference of thepriming process feature graphical element 510 to, e.g., graphicallyindicate the progression of the priming process (e.g., the circumferenceof the priming process feature graphical element 510 may represent 100%of the priming process and the circumferential indicator 507 mayindicate where along the circumference the priming process is presentlyat).

Further, the settings region 504 may include, or display, a plurality ofsettings and/or parameters related to priming. Some of the settings andparameters may be selectable by a user to change the settings orparameters. For example, a user has selected the sodium treatmentparameter 505 in FIG. 8A, and thus, a parameter selection element 506has been displayed that is configured to allow the user to change thevalue for the sodium treatment parameter 505.

After the priming is complete, the exemplary graphical user interface500 may be configured into a treatment mode as shown in FIG. 8B. Forexample, when in treatment mode, the operation region 502 may includeone or more process feature graphical elements for use in a treatmentand the settings region 504 may include one or more settings and/orparameters for use in a treatment. Additionally, the graphical userinterface 500 may be configured such that the operations region 502 maybe enlarged and the setting region 504 hidden as shown in FIG. 8C by,e.g., selection of minimize/maximize element 509.

The operation region 502 may include a blood process feature graphicalelement 512 (which, e.g., may be a stationary primary region orelement), a dialysate-related process feature graphical element 514, anultrafiltration process feature graphical element 516, and ananticoagulation process feature graphical element 518. Such processfeature graphical elements 512, 514, 516, 518 may be similar to theprocess feature graphical elements previously described herein. Forexample, when the process feature graphical elements 512, 514, 516, 518are separated by space 520 from each other, the process featuregraphical elements 512, 514, 516, 518 may be described to be in aninactive state, and in turn, the process features associated therewithand represented thereby are also in an inactive state.

Each process feature graphical elements 514, 516, 518 may be moved,e.g., either automatically by the system or by a user, to overlap theblood process feature graphical element 512 to indicate that the movedand overlapped process feature graphical element 514, 516, 518 are inthe active state. For example, as shown in FIG. 8D, the ultrafiltrationprocess feature graphical element 516 has been moved to overlap aportion or area of the blood process feature graphical element 512 to,e.g., indicate that the ultrafiltration process feature graphicalelement 518, and in turn, the ultrafiltration processes associatedtherewith and represented thereby, are active (e.g., ready for use,etc.). As shown, the ultrafiltration process feature graphical element516 and the blood process feature graphical element 512 may overlap todefine an overlap area 519 (e.g., similar to the overlapping areas ofcircles in Venn diagrams).

Likewise, the dialysate-related process feature graphical element 514and the anticoagulation process feature graphical element 518 may bemoved proximate to and overlapped with the blood process featuregraphical element 512 to, e.g., indicate that the dialysate-relatedprocess feature graphical element 514 and the anticoagulation processfeature graphical element 518, and in turn, the processes associatedtherewith and represented thereby, are active (e.g., ready for use,etc.) as shown in FIG. 8E. Additionally, the minimize/maximize element509 may be again selected when the operation region 502 is enlarged asshown in FIG. 8E to again return to the graphical user interface 500including a smaller operation region 502 with settings region 504 asshown in FIG. 8F.

All patents, patent documents, and references cited herein areincorporated in their entirety as if each were incorporated separately.This disclosure has been provided with reference to illustrativeembodiments and is not meant to be construed in a limiting sense. Asdescribed previously, one skilled in the art will recognize that othervarious illustrative applications may use the techniques as describedherein to take advantage of the beneficial characteristics of thesystems and methods described herein. Various modifications of theillustrative embodiments, as well as additional embodiments of thedisclosure, will be apparent upon reference to this description.

1. An extracorporeal blood treatment system comprising: extracorporealblood treatment apparatus for use during an extracorporeal bloodtreatment comprising a blood pressure sensor to sense a patient's bloodpressure; a display apparatus comprising a graphical user interfaceconfigured to depict a human-shaped graphical element and a heart-shapedgraphical element at least partially within the human-shaped graphicalelement; and a computing apparatus comprising one or more processors,wherein the computing apparatus is operatively coupled to theextracorporeal blood treatment apparatus and the display apparatus,wherein the computing apparatus is configured to: display on thegraphical user interface the human-shaped graphical element and theheart-shaped graphical element at least partially within thehuman-shaped graphical element using the one or more processors, allow auser to select the heart-shaped graphical element to initiate the bloodpressure sensor to perform a blood pressure measurement on the patient,determine the patient's blood pressure using the blood pressure sensorin response to selection of the heart-shaped graphical element, anddisplay the measured blood pressure of the patient on the graphical userinterface.
 2. (canceled)
 3. The system of claim 1, wherein the measuredblood pressure of the patient is displayed at least partially within thehuman-shaped graphical element on the graphical user interface.
 4. Thesystem of claim 1, wherein the computing apparatus is further configuredto, upon initialization of the blood pressure sensor to perform a bloodpressure measurement on the patient, graphically animate theheart-shaped graphical element to indicate that the user has initiated ablood pressure measurement and that the blood pressure measurement isoccurring using the blood pressure sensor.
 5. The system of claim 4,wherein the graphical animation of the heart-shaped graphical elementcomprises the heart-shaped graphical element pulsating.
 6. The system ofclaim 1, wherein the extracorporeal blood treatment apparatus furthercomprises a heart rate sensor to measure the patient's heart rate,wherein the computing apparatus is further configured to: allow a userto select a heart rate area of the human-shaped graphical element toinitiate the heart rate sensor to perform a heart rate measurement;determine the patient's heart rate using the heart rate sensor inresponse to selection of the heart rate area of the human-shapedgraphical element; and display the measured heart rate of the patient onthe graphical user interface.
 7. The system of claim 1, wherein theextracorporeal blood treatment apparatus comprises one or more wastesensors to determine an amount of waste being removed from the patient,wherein the human-shaped graphical element comprises graphical indiciaindicative of the amount of waste removed from the patient.
 8. Thesystem of claim 1, wherein the human-shaped graphical element comprisesa graphical facial expression configured to indicate happiness when anextracorporeal blood treatment is complete.
 9. The system of claim 1,wherein the graphical user interface is configured to depict a graphicalrepresentation of at least one of the venous and arterial blood linesextending from the human-shaped graphical element and another graphicalelement on the graphical user interface to indicate that venous andarterial blood lines are connecting the patient to a blood circuit ofthe extracorporeal blood treatment apparatus.
 10. The system of claim 9,wherein the extracorporeal blood treatment apparatus comprises one ormore blood circuit pressure sensors to measure venous blood circuitpressure and arterial blood circuit pressure in the blood circuit,wherein the graphical user interface is further configured to depict ablood circuit pressure graphical representation representative of atleast one of venous blood pressure of the patient and arterial bloodpressure of the patient measured by the one or more blood circuitpressure sensors proximate the graphical depiction of at least one ofthe venous and arterial blood lines.
 11. The system of claim 1, whereinthe computing apparatus is further configured to allow a user to selecta graphical area proximate or within the human-shaped graphical elementto display a patient information region on the graphical user interfacecomprising patient-related information, wherein the patient-relatedinformation comprises at least one of a prescription, medicationcondition history, treatment history, a treatment summary, patientnotes, and vital signs.
 12. The system of claim 1, wherein the computingapparatus is further configured to display on the graphical userinterface a blood process feature graphical element using the one ormore processors, wherein the human-shaped graphical element and theblood process feature graphical element are separated by space, whereinthe human-shaped graphical element is movable proximate the bloodprocess feature graphical element to indicate that venous and arterialblood lines are connecting the patient to a blood circuit of theextracorporeal blood treatment apparatus.
 13. The system of claim 12,wherein the human-shaped graphical element further comprises aconnection area corresponding to the blood process feature graphicalelement and the blood process feature graphical element comprises aconnection area corresponding to the human-shaped graphical element,wherein the connection area of the human-shaped graphical element is atleast proximate to the connection area of the blood process featuregraphical element when the human-shaped graphical element is proximatethe blood process feature graphical element to indicate that venous andarterial blood lines are connecting the patient to the blood circuit ofthe extracorporeal blood treatment apparatus.
 14. The system of claim13, wherein the connection area of the human-shaped graphical element isconfigured to be in at least contact with the connection area of theblood process feature graphical element when the human-shaped graphicalelement is proximate the blood process feature graphical element. 15.The system of claim 1, wherein the display apparatus comprises atouchscreen.
 16. A method for an extracorporeal blood treatment systemcomprising: providing extracorporeal blood treatment apparatus for useduring an extracorporeal blood treatment comprising a blood pressuresensor to sense a patient's blood pressure; displaying on a graphicaluser interface a human-shaped graphical element and the heart-shapedgraphical element within the human-shaped graphical element; allowing auser to select the heart-shaped graphical element to initiate the bloodpressure sensor to perform a blood pressure measurement on the patient;determining the patient's blood pressure using the blood pressure sensorin response to selection of the heart-shaped graphical element; anddisplaying the measured blood pressure of the patient on the graphicaluser interface.
 17. The method of claim 16, wherein the measured bloodpressure of the patient is displayed at least partially within thehuman-shaped graphical element on the graphical user interface.
 18. Themethod of claim 16, wherein the method further comprises, uponinitialization of the blood pressure sensor to perform a blood pressuremeasurement on the patient, graphically animating the heart-shapedgraphical element to indicate that the user has initiated a bloodpressure measurement and that the blood pressure measurement isoccurring using the blood pressure sensor.
 19. The method of claim 16,wherein the extracorporeal blood treatment apparatus further comprises aheart rate sensor to measure the patient's heart rate, wherein themethod further comprises: allowing a user to select a heart rate area ofthe human-shaped graphical element to initiate the heart rate sensor toperform a heart rate measurement; determining the patient's heart rateusing the heart rate sensor in response to selection of the heart ratearea of the human-shaped graphical element; and displaying the measuredheart rate of the patient on the graphical user interface.
 20. Themethod of claim 16, wherein the extracorporeal blood treatment apparatuscomprises one or more waste sensors to determine an amount of wastebeing removed from the patient, wherein the human-shaped graphicalelement comprises graphical indicia indicative of the amount of wasteremoved from the patient.